{
  "meta": {
    "title": "00367_Late_Night_Pyq_Inicet_Obg-4",
    "url": "https://brainandscalpel.vercel.app/00367-late-night-pyq-inicet-obg-4-1879448a.html",
    "scrapedAt": "2025-11-29T18:10:41.081Z"
  },
  "questions": [
    {
      "id": 74678,
      "choices": [
        {
          "id": 297625,
          "text": "<p><span style=\"font-size:16px;\">Head rotated by 1/8<sup>th</sup> of a circle</span></p>"
        },
        {
          "id": 297626,
          "text": "<p><span style=\"font-size:16px;\">Head rotating due to untwisting of the neck</span></p>"
        },
        {
          "id": 297627,
          "text": "<p><span style=\"font-size:16px;\">The shoulder undergoing rotation by 1/8<sup>th</sup> of circle&nbsp;</span></p>"
        },
        {
          "id": 297628,
          "text": "<p><span style=\"font-size:16px;\">The movement by which the head is born&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is restitution? (INICET NOV 2024)</span></p>",
      "unique_key": "Q7241133",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770714,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Head rotating due to untwisting of the neck</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Restitution is one of the <strong>cardinal movements of labor</strong> that occurs after the delivery of the fetal head. During internal rotation, the fetal neck gets <strong>twisted by 45 degrees</strong> (for example, in <strong>Left Occipital Anterior position).</strong> Once the head is delivered and free from the bony confines of the pelvis, it naturally <strong>untwists to align with the fetal body</strong>. This untwisting movement of the head is called restitution.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_FLKY4PB.png\" width=\"508\" height=\"324\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Head rotated by 1/8th of a circle:</strong> Incorrect. Restitution isn't defined by the degree of rotation (though a 45-degree rotation is approximately 1/8th of a circle). Rather, restitution specifically refers to the untwisting mechanism and its purpose.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. The shoulder undergoing rotation by 1/8th of circle:</strong> Incorrect. Shoulder rotation occurs after restitution and is part of a different cardinal step called external rotation. During external rotation, the shoulders enter the pelvis and undergo internal rotation, which manifests as the head rotating externally.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. The movement by which the head is born:&nbsp;</strong>Incorrect. This describes extension, which is the movement that occurs when the head is being delivered, before restitution takes place.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Restitution is the untwisting movement of the fetal head that occurs after delivery of the head, correcting the twist that occurred during internal rotation.</span></p>",
      "correct_choice_id": 297626,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6114,
      "choices": [
        {
          "id": 24425,
          "text": "<p><span style=\"font-size:12pt;\">3, 1, 2, 4</span></p>"
        },
        {
          "id": 24426,
          "text": "<p><span style=\"font-size:12pt;\">3, 2, 4, 1</span></p>"
        },
        {
          "id": 24427,
          "text": "<p><span style=\"font-size:12pt;\">2, 4, 3, 1</span></p>"
        },
        {
          "id": 24428,
          "text": "<p><span style=\"font-size:12pt;\">2, 4, 1, 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Consider the following actions under AMTSL. Arrange them in the right order?&nbsp;</span>(INICET NOV 2022)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Uterine tone assessment</span></li><li><span style=\"font-size:12pt;\">Give uterotonic (oxytocin 10 mg)</span></li><li><span style=\"font-size:12pt;\">Exclude the presence of another fetus</span></li><li><span style=\"font-size:12pt;\">Controlled cord traction</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\">AMTSL- Active management of the third stage of labor.</span></p>",
      "unique_key": "Q5244659",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770385,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 3, 2, 4, 1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Active Management of 3<sup>rd</sup> Stage of Labor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Active Management of the Third Stage of Labor (AMTSL) is a set of interventions aimed at preventing postpartum hemorrhage (PPH). The correct order of actions is:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>3. Exclude the presence of another fetus</strong>: Ensure there is no additional fetus before administering any uterotonic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2. Give uterotonic (oxytocin 10 mg)</strong>: Administer a uterotonic drug to help the uterus contract and reduce bleeding. It is given after the delivery of baby.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>4. Controlled cord traction</strong>: Perform controlled traction on the umbilical cord to deliver the placenta.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>1. Uterine tone assessment</strong>:<strong> </strong>assess the uterine tone every 15 minutes to detect uterine atony.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The steps of Active Management of the Third Stage of Labor (AMTSL) should be followed in a specific order: exclude the presence of another fetus, administer a uterotonic, perform controlled cord traction, and then assess the uterine tone.</span></p>",
      "correct_choice_id": 24426,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20480,
      "choices": [
        {
          "id": 81882,
          "text": "<p><span style=\"font-size:12pt;\">Tubal ligation</span></p>"
        },
        {
          "id": 81883,
          "text": "<p><span style=\"font-size:12pt;\">Asherman syndrome</span></p>"
        },
        {
          "id": 81884,
          "text": "<p><span style=\"font-size:12pt;\">Endocervical polyp</span></p>"
        },
        {
          "id": 81885,
          "text": "<p><span style=\"font-size:12pt;\">Subserosal fibroid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In which of the following conditions, hysteroscopy can be done? (NEET PG 2023)</span></p>",
      "unique_key": "Q7270227",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771248,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Asherman syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Hysteroscopy is the treatment of choice in Asherman syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Asherman Syndrome</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">These are intra-uterine adhesions</span></li><li><span style=\"font-size:12pt;\">They usually follow a history of sharp curettage</span></li><li><span style=\"font-size:12pt;\">Symptoms are hypomenorrhea, secondary amenorrhoea and secondary infertility</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Diagnosis –</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">TVS: broken/ irregular endometrium</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">HSG: space filling defect is seen (moth eaten appearance)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Ix of choice: Hysteroscopy</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Treatment - Hysteroscopic adhesiolysis</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/10/screenshot-2024-08-10-175609.png\" alt=\"\" width=\"400\" height=\"537\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Tubal ligation</strong>: Tubal ligation is done via laparoscopy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Endocervical polyp</strong>: In Endocervical polyps’ cases surgical ligation and excision can be done if severe bleeding is expected. Hysteroscopy can help visualisation and assessment but it is not the primary method for managing endocervical polyps.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Subserosal fibroid:</strong> In cases of Subserosal fibroids an MRI helps in detailed mapping of the fibroids if a myomectomy is planned.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Hysteroscopy is the treatment of choice in Asherman syndrome.</span></p>",
      "correct_choice_id": 81883,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56975,
      "choices": [
        {
          "id": 227289,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anencephaly</span></span></span></p>"
        },
        {
          "id": 227290,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Encephalocele</span></span></span></p>"
        },
        {
          "id": 227291,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lissencephaly</span></span></span></p>"
        },
        {
          "id": 227292,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Holoprosencephaly</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Identify the anomaly seen on the ultrasound.&nbsp;</span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2024)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-121742.jpg\" style=\"height:212px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q7917010",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771240,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Anencephaly</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The ultrasound image shows a characteristic &quot;frog face&quot; appearance, which is highly indicative of anencephaly. Anencephaly is a severe congenital condition where a major portion of the brain, skull, and scalp is absent. This condition can be identified as early as 12 to 14 weeks of gestation via ultrasound. The typical appearance on the ultrasound includes the absence of the cranial vault and cerebral hemispheres, resulting in the recognizable frog-like appearance of the fetus&rsquo;s head.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Encephalocele:</span></strong><span style=\"font-size:12.0pt\"> This is incorrect. Encephalocele is a neural tube defect characterized by a sac-like protrusion of the brain and membranes through an opening in the skull. It does not present with the &ldquo;frog face&rdquo; appearance.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Lissencephaly:</span></strong><span style=\"font-size:12.0pt\"> This is incorrect. Lissencephaly is a brain malformation characterized by the absence of normal brain folds (gyri) and is not associated with the absence of the skull or the typical features seen in the image.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Holoprosencephaly:</span></strong><span style=\"font-size:12.0pt\"> This is incorrect. Holoprosencephaly involves the failure of the brain to divide into two hemispheres and has a different ultrasound appearance, often showing facial anomalies like a single eye or cleft palate, but not the frog-like appearance seen in anencephaly.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anencephaly presents on ultrasound with a distinct &quot;frog face&quot; appearance due to the absence of the cranial vault and cerebral hemispheres. It can be diagnosed early in pregnancy, typically around 12 to 14 weeks.</span></span></span></p>",
      "correct_choice_id": 227289,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56831,
      "choices": [
        {
          "id": 226717,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placenta previa</span></span></p>"
        },
        {
          "id": 226718,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placenta accrete syndrome</span></span></p>"
        },
        {
          "id": 226719,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abruptio placentae</span></span></p>"
        },
        {
          "id": 226720,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rupture uterus</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A G2 with a previous LSCS underwent cesarean delivery. During surgery, there was excessive bleeding, and a hysterectomy had to be done. The image of the uterus is shown. What is the probable diagnosis? (NEET PG 2024)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-11-111039.jpg\" style=\"height:324px; width:300px\" /></span></span></p>",
      "unique_key": "Q3641612",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770832,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><span style=\"font-size:12.0pt\">&nbsp;<strong>B) Placenta accrete syndrome</strong></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Placenta accrete syndrome (PAS) includes conditions where the placenta abnormally attaches to the uterus, such as placenta accreta, increta, and percreta. In this case, the image and description of the uterus with the placenta still attached indicate PAS. The typical presentation involves severe intraoperative bleeding because the placenta does not detach easily from the uterine wall, necessitating an obstetric hysterectomy to control the hemorrhage. This condition is common in patients with a history of cesarean sections (LSCS) due to scarring in the uterine wall, making placental attachment more likely. Diagnosing PAS antenatally can alter management strategies, such as planning an <strong>elective upper segment cesarean section</strong> <strong>between 34-37 weeks</strong> and avoiding the lower uterine segment to minimize bleeding and complications. After delivering the baby, the placenta should be left in situ, followed by an immediate obstetric hysterectomy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Placenta previa:</span></strong><span style=\"font-size:12.0pt\"> Placenta previa occurs when the placenta covers the cervix, leading to painless bleeding during pregnancy but not typically associated with an adherent placenta that requires hysterectomy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Abruptio placentae:</span></strong><span style=\"font-size:12.0pt\"> This condition involves premature placental detachment from the uterine wall, leading to painful bleeding. However, it does not involve a placenta that remains attached and does not generally necessitate a hysterectomy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Rupture uterus:</span></strong><span style=\"font-size:12.0pt\"> Uterine rupture involves a tear in the uterine wall, often resulting from previous uterine surgeries. It presents with acute pain and significant bleeding, but the description and image do not match the typical findings of PAS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Placenta accrete syndrome involves abnormal placental adherence to the uterine wall, often leading to severe bleeding during delivery and requiring obstetric hysterectomy.</span></span></span></p>",
      "correct_choice_id": 226718,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74680,
      "choices": [
        {
          "id": 297633,
          "text": "<p><span style=\"font-size:16px;\">Bimanual compression</span></p>"
        },
        {
          "id": 297634,
          "text": "<p><span style=\"font-size:16px;\">Uterine massage</span></p>"
        },
        {
          "id": 297635,
          "text": "<p><span style=\"font-size:16px;\">CCT</span></p>"
        },
        {
          "id": 297636,
          "text": "<p><span style=\"font-size:16px;\">Administration of oxytocics</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which step is not included in active management of third stage of labor (AMTSL)? (INICET NOV 2024)</span></p>",
      "unique_key": "Q1898338",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770716,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Bimanual compression</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Active Management of Third Stage of Labor (AMTSL) consists of three basic components as defined by WHO in the early 2000s:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>Administration of oxytocics (primarily oxytocin)</strong></span></li><li><span style=\"font-size:16px;\"><strong>Controlled Cord Traction (CCT)</strong></span></li><li><span style=\"font-size:16px;\"><strong>Uterine massage (now termed as postpartum vigilance)</strong></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\">An additional component that has been recently added is <strong>delayed cord clamping</strong>, though this is primarily for preventing neonatal anemia rather than preventing postpartum hemorrhage.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong> <strong>B. Uterine massage:&nbsp;</strong>Uterine massage is a core component of AMTSL. While the terminology has evolved to \"<strong>postpartum vigilance,</strong>\" it remains an essential step where the uterus is checked and massaged if not well contracted.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong> <strong>C. CCT (Controlled Cord Traction):&nbsp;</strong>CCT is one of the three basic steps of AMTSL.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong> <strong>D. Administration of oxytocics:&nbsp;</strong>Administration of oxytocics, particularly oxytocin, is the first and crucial step of AMTSL.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Bimanual compression is a treatment method for atonic postpartum hemorrhage, not a preventive measure in AMTSL. The three basic components of AMTSL are: <strong>administration of oxytocics, controlled cord traction, and uterine massage/postpartum vigilance.</strong></span></p>",
      "correct_choice_id": 297633,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74706,
      "choices": [
        {
          "id": 297737,
          "text": "<p><span style=\"font-size:16px;\">MRI</span></p>"
        },
        {
          "id": 297738,
          "text": "<p><span style=\"font-size:16px;\">Surgical exploration</span></p>"
        },
        {
          "id": 297739,
          "text": "<p><span style=\"font-size:16px;\">Follow up</span></p>"
        },
        {
          "id": 297740,
          "text": "<p><span style=\"font-size:16px;\">Measure Ca – 125</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A 24-year-old P1L1 woman presented with acute abdominal pain. She has a H/O RHD and recently went for mitral valve replacement and is currently on warfarin therapy. On examination, there is a 14-week size abdominal pelvic mass and on USG, a 6 × 8 cm unilocular cyst with reticular appearance is seen. What is the next best step in management of this patient? (INICET NOV 2024)</span></p>",
      "unique_key": "Q2981184",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770829,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Surgical exploration</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In this case, surgical exploration is the best next step because:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">The patient has a large (6×8 cm) symptomatic ovarian cyst with reticular appearance suggesting hemorrhage</span></li><li><span style=\"font-size:16px;\">The hemorrhagic nature is <strong>likely due to warfarin therapy</strong></span></li><li><span style=\"font-size:16px;\">Due to the large size and symptoms (acute abdominal pain), conservative management is not appropriate</span></li><li><span style=\"font-size:16px;\">However, before surgery:&nbsp;</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Anticoagulation needs to be stopped</span></li><li><span style=\"font-size:16px;\">INR needs to be corrected <strong>(may require vitamin K</strong>)</span></li><li><span style=\"font-size:16px;\">Patient may need <strong>bridging with heparin</strong></span></li><li><span style=\"font-size:16px;\">Surgery should be performed only after coagulation parameters are normalized</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. MRI:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Not necessary as USG has already provided clear visualization of the cyst</span></li><li><span style=\"font-size:16px;\">Won't add significant diagnostic value given the clear hemorrhagic appearance on USG</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Follow up:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Not appropriate for a large (6*8 cm) symptomatic cyst</span></li><li><span style=\"font-size:16px;\">Conservative management is suitable for smaller, asymptomatic cysts</span></li><li><span style=\"font-size:16px;\">Risk of continued hemorrhage due to anticoagulation</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Measure Ca-125:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Not indicated as the imaging characteristics suggest a benign hemorrhagic cyst</span></li><li><span style=\"font-size:16px;\">Patient is young and USG findings are not suspicious for malignancy</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Large hemorrhagic ovarian cysts in patients on anticoagulation require <strong>surgical management</strong> after correcting coagulation parameters.</span></p>",
      "correct_choice_id": 297738,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74693,
      "choices": [
        {
          "id": 297685,
          "text": "<p><span style=\"font-size:16px;\">Vigorous term babies not requiring resuscitation</span></p>"
        },
        {
          "id": 297686,
          "text": "<p><span style=\"font-size:16px;\">All preterm babies irrespective of birth weight</span></p>"
        },
        {
          "id": 297687,
          "text": "<p><span style=\"font-size:16px;\">Vigorous term and preterm babies not requiring resuscitation</span></p>"
        },
        {
          "id": 297688,
          "text": "<p><span style=\"font-size:16px;\">All term babies irrespective of birth weight</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">When is delayed cord clamping done? (INICET NOV 2024)</span></p>",
      "unique_key": "Q1900621",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770824,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Vigorous term and preterm babies not requiring resuscitation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">According to WHO guidelines, delayed cord clamping should be performed in all vigorous term and preterm babies <strong>who do not require resuscitation</strong>. This practice has been incorporated into the <strong>active management of third stage of labor (AMTSL) protocol</strong>. The primary benefit is the prevention of neonatal anemia, with particular effectiveness in preterm infants.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Vigorous term babies not requiring resuscitation:&nbsp;</strong>Incorrect because it excludes preterm babies, who benefit more from delayed cord clamping</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. All preterm babies irrespective of birth weight:&nbsp;</strong>Incorrect because it includes preterm babies requiring resuscitation, which is a contraindication for delayed cord clamping</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. All term babies irrespective of birth weight:&nbsp;</strong>Incorrect because it includes babies requiring resuscitation, which is a contraindication for delayed cord clamping</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Delayed cord clamping should be performed in all vigorous term and preterm babies not requiring resuscitation, with the only contraindication being the need for immediate resuscitation in an asphyxiated baby.</span></p>",
      "correct_choice_id": 297687,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56834,
      "choices": [
        {
          "id": 226729,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">3 cm anterior to the posterior fontanelle</span></span></span></p>"
        },
        {
          "id": 226730,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">6 cm anterior to the posterior fontanelle</span></span></span></p>"
        },
        {
          "id": 226731,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">4 cm anterior to the posterior fontanelle</span></span></span></p>"
        },
        {
          "id": 226732,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Midway between the anterior and posterior fontanelle</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">You are applying a vacuum to deliver a baby in a patient with prolonged 2nd stage. The point at which the vacuum is applied is: (NEET PG 2024)</span></span></p>",
      "unique_key": "Q2109324",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770855,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) 3 cm anterior to the posterior fontanelle</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>Ans.</strong> is <strong>3 cm anterior to the posterior fontanelle</strong>, which is the location known as the <strong>flexion point</strong>. The flexion point is critical in vacuum-assisted deliveries because it lies 3 cm anterior to the posterior fontanelle on the baby&#39;s head. This point is chosen because pulling on this location causes flexion of the baby&#39;s head, facilitating the proper positioning for delivery. Flexion is crucial as it allows the smallest diameter of the baby&#39;s head to present, making the delivery process smoother and safer for both the mother and baby.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The flexion point, located 3 cm anterior to the posterior fontanelle, is the optimal site for applying a vacuum during delivery to achieve the necessary head flexion.</span></span></p>",
      "correct_choice_id": 226729,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InstrumentsBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20484,
      "choices": [
        {
          "id": 81898,
          "text": "<p><span style=\"font-size:12pt;\">Chemotherapy</span></p>"
        },
        {
          "id": 81899,
          "text": "<p><span style=\"font-size:12pt;\">Brachytherapy</span></p>"
        },
        {
          "id": 81900,
          "text": "<p><span style=\"font-size:12pt;\">Chemoradiation</span></p>"
        },
        {
          "id": 81901,
          "text": "<p><span style=\"font-size:12pt;\">Surgery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old woman presents with foul-smelling bloody discharge per vagina mixed with mucous discharge. On examination, a necrotizing growth is seen in the cervix with lateral parametrium involvement. What will be the management for this patient? (NEET PG 2023)</span></p>",
      "unique_key": "Q4896399",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771250,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Chemoradiation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The patient presents with a foul-smelling bloody discharge mixed with mucous discharge, and a necrotizing growth in the cervix with lateral parametrium involvement. These clinical features are suggestive of advanced cervical cancer. The involvement of the lateral parametrium indicates that the cancer has spread beyond the cervix to the surrounding tissues but not to the pelvic wall or the lower third of the vagina, which classifies it as Stage 2B cervical cancer. The standard treatment for Stage 2B cervical cancer is chemoradiation, which combines chemotherapy with radiation therapy. This approach aims to enhance the effectiveness of the treatment, reduce tumor size, and prevent further spread of the cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Chemotherapy:</strong> Chemotherapy alone is not the standard treatment for Stage 2B cervical cancer. It may be used in conjunction with radiation, but not as a sole therapy in this stage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Brachytherapy:</strong> Brachytherapy, a form of internal radiation therapy, is typically used for early-stage cervical cancer or in combination with external beam radiation therapy for more advanced stages. However, it is not sufficient as a standalone treatment for Stage 2B.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Surgery:</strong> Surgery is generally not recommended for Stage 2B cervical cancer due to the extent of the disease spread to the parametrium. The preferred approach is chemoradiation to address both local and regional disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Stage 2B cervical cancer, characterized by lateral parametrium involvement, is best managed with chemoradiation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Staging of CA Cervix</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/10/screenshot-2024-08-10-180546.png\" alt=\"\" width=\"1000\" height=\"594\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">TREATMENT</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Surgery: for early stages like stage 1, stage 2A1</span></li><li><span style=\"font-size:12pt;\">Radiotherapy: for all patients from Stage 1 to 4</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/whatsapp-image-2023-06-12-at-1901210146.jpg\" alt=\"\" width=\"1000\" height=\"246\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Chemoradiation can be offered at all stages</span></p>",
      "correct_choice_id": 81900,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44007,
      "choices": [
        {
          "id": 175687,
          "text": "<p><span style=\"font-size:12pt;\">Debulking followed by radiotherapy</span></p>"
        },
        {
          "id": 175688,
          "text": "<p><span style=\"font-size:12pt;\">Debulking followed by chemotherapy</span></p>"
        },
        {
          "id": 175689,
          "text": "<p><span style=\"font-size:12pt;\">Chemotherapy followed by debulking</span></p>"
        },
        {
          "id": 175690,
          "text": "<p><span style=\"font-size:12pt;\">Staging laparotomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old woman with epithelial ovarian cancer has peritoneal metastases and ascites. What is the management?&nbsp;</span>(INICET NOV 2023)</p>",
      "unique_key": "Q1393497",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770392,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Debulking followed by chemotherapy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For advanced ovarian cancer with peritoneal metastases and ascites, the preferred treatment is surgical debulking followed by chemotherapy. This approach helps reduce tumor load and enhances chemotherapy effectiveness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Debulking followed by radiotherapy:</strong> Radiotherapy is not typically used as a first-line treatment in ovarian cancer with peritoneal metastases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Chemotherapy followed by debulking:</strong> Starting with chemotherapy may be considered, but debulking first is usually preferred.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Staging laparotomy:</strong> Staging laparotomy is primarily diagnostic, not therapeutic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In advanced epithelial ovarian cancer with peritoneal involvement, initial surgical debulking followed by chemotherapy is the standard management approach to maximize treatment efficacy.</span></p>",
      "correct_choice_id": 175688,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6101,
      "choices": [
        {
          "id": 24373,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 3</span></span></span></p>"
        },
        {
          "id": 24374,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2</span></span></span></p>"
        },
        {
          "id": 24375,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 4</span></span></span></p>"
        },
        {
          "id": 24376,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3, 4</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman presents at 8 weeks of gestation. Which of the following signs can be elicited at this gestation?&nbsp;</span></span></span>(INICET NOV 2022)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Goodell&#39;s sign</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Osiander&#39;s sign</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Internal ballottement</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lightening</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>",
      "unique_key": "Q8055607",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770382,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 1, 2</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Goodell&#39;s sign</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This sign is the softening of the cervix, which can be elicited around the 6th week of gestation.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Osiander&#39;s sign</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This sign refers to the increased pulsation felt through the lateral fornices, which can be detected between 6 to 8 weeks of gestation.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Internal ballottement</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This can be elicited between the 16th and 28th weeks of gestation when the fetus can be felt to move away and return to the fingers upon gentle tap on the cervix.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lightening</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a sensation of relief of the pressure symptoms due to the engagement of the presenting part, typically felt around 38 weeks of gestation.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 1, 3</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Internal ballottement cannot be elicited at 8 weeks of gestation as it is typically felt between 16 and 28 weeks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. 1, 4</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lightening is not experienced until about 38 weeks of gestation, making this option incorrect.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. 3, 4</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Neither internal ballottement nor lightening can be elicited at 8 weeks of gestation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The signs that can be elicited at 8 weeks of gestation are Goodell&#39;s sign (softening of the cervix) and Osiander&#39;s sign (increased pulsation felt through the lateral fornices).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Signs in early pregnancy are as shown below</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/02/untitled-290.jpg\" style=\"height:580px; width:900px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Dutta&rsquo;s textbook of obstetrics 8<sup>th</sup> edition pg 74</span></strong></span></span></p>",
      "correct_choice_id": 24374,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74683,
      "choices": [
        {
          "id": 297645,
          "text": "<p><span style=\"font-size:16px;\">Anatomical conjugate</span></p>"
        },
        {
          "id": 297646,
          "text": "<p><span style=\"font-size:16px;\">Diagonal conjugate</span></p>"
        },
        {
          "id": 297647,
          "text": "<p><span style=\"font-size:16px;\">Obstetric conjugate</span></p>"
        },
        {
          "id": 297648,
          "text": "<p><span style=\"font-size:16px;\">True conjugate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Shortest anterior posterior diameter of the pelvic inlet: (INICET NOV 2024)</span></p>",
      "unique_key": "Q5921414",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770819,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Obstetric conjugate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The obstetric conjugate is the <strong>shortest anterior-posterior diameter</strong> of the pelvic inlet through which the baby passes during delivery. It extends from the <strong>sacral promontory to a point on the posterior surface of the pubic symphysis.</strong> This is the clinically significant diameter as it represents the actual space available for fetal descent.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_VMSRcb2.png\" width=\"769\" height=\"597\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Anatomical conjugate (also called true conjugate):</strong> This extends from the <strong>sacral promontory to the upper border of pubic symphysis</strong>. While it is a pelvic measurement, it has no clinical significance.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Diagonal conjugate:</strong> This is measured during pelvic examination from the <strong>sacral promontory to the lower border of pubic symphysis.&nbsp;</strong>When 1.5 cm is subtracted from the diagonal conjugate, we get the obstetric conjugate.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>&nbsp;Option D. True conjugate:</strong> This is the same as the anatomical conjugate<strong>, extending</strong> from the sacral promontory to the upper border of pubic symphysis. It has no clinical significance.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The obstetric conjugate is the shortest and most clinically significant anterior-posterior diameter of the pelvic inlet, measuring from the sacral promontory to the posterior surface of the pubic symphysis. The diagonal conjugate can be measured clinically, and subtracting 1.5 cm from it gives the obstetric conjugate.</span></p>",
      "correct_choice_id": 297647,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44010,
      "choices": [
        {
          "id": 175699,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Remove placenta and reposition the uterus</span></span></span></p>"
        },
        {
          "id": 175700,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Put uterus inside without removing the placenta</span></span></span></p>"
        },
        {
          "id": 175701,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Shift to OT and insert the uterus back</span></span></span></p>"
        },
        {
          "id": 175702,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start Oxytocin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient has just delivered a full-term baby and developed uterine inversion with the placenta still attached. What is the immediate next step?&nbsp;</span></span>(INICET NOV 2023)</p>",
      "unique_key": "Q3668794",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770395,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Put uterus inside without removing the placenta</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immediate management of uterine inversion involves repositioning the uterus before removing the placenta to prevent severe bleeding and shock.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Remove placenta and reposition the uterus:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Removing the placenta before repositioning the uterus can lead to massive hemorrhage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Shift to OT and insert the uterus back:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Immediate manual repositioning is crucial before shifting to an operating theatre.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Start Oxytocin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Oxytocin is used after the uterus is repositioned to encourage contraction, not before.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the case of uterine inversion, the uterus should be repositioned with the placenta still attached to avoid significant bleeding, followed by medical management for uterine contraction.</span></span></span></p>",
      "correct_choice_id": 175700,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56843,
      "choices": [
        {
          "id": 226765,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">48hrs</span></span></p>"
        },
        {
          "id": 226766,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">48hrs &ndash; 6 weeks</span></span></p>"
        },
        {
          "id": 226767,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">24hrs</span></span></p>"
        },
        {
          "id": 226768,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">12hrs</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IUCD can be inserted after delivery till? (NEET PG 2024)</span></span></p>",
      "unique_key": "Q2679590",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770857,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans</span></strong><span style=\"font-size:12.0pt\">. <strong>A) 48hrs</strong></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">An Intrauterine Contraceptive Device (IUCD), specifically the Copper T, can be inserted immediately after delivery as part of postpartum family planning. The optimal time frames for insertion include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Post-placental insertion:</span></strong><span style=\"font-size:12.0pt\"> Within 10 minutes of placental delivery, commonly done when the patient is highly motivated.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Early postpartum insertion:</span></strong><span style=\"font-size:12.0pt\"> From 10 minutes up to 48 hours after delivery.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Intra-caesarean insertion:</span></strong><span style=\"font-size:12.0pt\"> At the time of cesarean section.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Late postpartum </span></strong><span style=\"font-size:12.0pt\">&ndash; After 6 weeks&nbsp; </span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Early postpartum IUCD insertion is considered safe and effective during this period due to the lower risk of expulsion and higher motivation of the patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Note -&nbsp; 48hrs to 6 weeks&rsquo;&nbsp;</span></strong><span style=\"font-size:12.0pt\">period is not suitable for IUCD insertion due to the high risk of expulsion and complications as the uterus is actively involuting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IUCD can be inserted within 48 hours of delivery, but not between 48 hours to 6 weeks due to the high risk of expulsion during this time.</span></span></span></p>",
      "correct_choice_id": 226765,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20478,
      "choices": [
        {
          "id": 81874,
          "text": "<p><span style=\"font-size:12pt;\">Forceps-assisted delivery</span></p>"
        },
        {
          "id": 81875,
          "text": "<p><span style=\"font-size:12pt;\">Vacuum-assisted delivery</span></p>"
        },
        {
          "id": 81876,
          "text": "<p><span style=\"font-size:12pt;\">Oxytocin infusion</span></p>"
        },
        {
          "id": 81877,
          "text": "<p><span style=\"font-size:12pt;\">Cesarean section</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A partogram of a woman in labor is shown below. Oxytocin infusion has been administered. Mark the best management for the patient?&nbsp;(NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/whatsapp-image-2023-06-12-at-1901210142.jpg\" alt=\"\" width=\"700\" height=\"830\"></span></p>",
      "unique_key": "Q5466873",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771246,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Cesarean section</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The above partogram suggests that the woman has cephalopelvic disproportion, for which the management would be to perform an emergency caesarean section.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">According to the above given partogram, findings are</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Cervix is fully dilated</span></li><li><span style=\"font-size:12pt;\">Moulding is 2+ = Sutures are overlapped but reducible</span></li><li><span style=\"font-size:12pt;\">Station is 3+</span></li><li><span style=\"font-size:12pt;\">Oxytocin infusion administered.</span></li><li><span style=\"font-size:12pt;\">Uterine contractions - Adequate.</span></li><li><span style=\"font-size:12pt;\">Amniotic fluid - M = Meconium-stained fluid</span></li><li><span style=\"font-size:12pt;\">Fetal heart rate – Deceleration = Baby is in distress</span></li><li><span style=\"font-size:12pt;\">Descent: Head is 3/5<sup>th</sup> palpable; this means that an instrument cannot be applied. For either forceps of vacuum to be applied, the head should not be palpable per abdomen.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In case of fetal distress, the management is an emergency cesarean section, not instrumental delivery or elective cesarean section.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Cephalopelvic disproportion means there is a disproportion in the fetal head and pelvis.&nbsp;It could be due to a Contracted pelvis or large baby (Macrosomia)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Degrees of Disproportion</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Severe degree contracted pelvis: Obstetric conjugate &lt; 7.5 cm</span></li><li><span style=\"font-size:12pt;\">Moderate degree: Obstetric conjugate between 7.5 to 9.5 cm</span></li><li><span style=\"font-size:12pt;\">Borderline pelvis: Obstetric conjugate measures between 9.5 to 10 cm</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Obstructed labor is one where despite good uterine contractions, the progressive descent of the presenting part is arrested due to mechanical obstruction. Cephalopelvic disproportion and contracted pelvis are the common causes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">A cesarean section at term is should be done in these cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Forceps-assisted delivery:&nbsp;</strong>Not suitable because the head is still palpable per abdomen and forceps cannot be applied.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Vacuum-assisted delivery:&nbsp;</strong>Not appropriate due to the same reason as above; the head is still palpable per abdomen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Oxytocin infusion:&nbsp;</strong>Oxytocin infusion is already being administered, and increasing or continuing it won't resolve the issue of cephalopelvic disproportion and fetal distress.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In cases of cephalopelvic disproportion and fetal distress, as indicated by a partogram, the management should be an emergency cesarean section.</span></p>",
      "correct_choice_id": 81877,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44008,
      "choices": [
        {
          "id": 175691,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brenner tumor</span></span></span></p>"
        },
        {
          "id": 175692,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arrhenoblastoma</span></span></span></p>"
        },
        {
          "id": 175693,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carcinoid tumor of the ovary</span></span></span></p>"
        },
        {
          "id": 175694,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Theca cell tumor</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is a virilizing ovarian tumor?&nbsp;</span></span>(INICET NOV 2023)</p>",
      "unique_key": "Q7036757",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770393,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Arrhenoblastoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arrhenoblastoma, also known as Sertoli-Leydig cell tumor, is a virilizing ovarian tumor that can produce androgens leading to masculinization.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Brenner tumor:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brenner tumors are epithelial ovarian cancer</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Carcinoid tumor of the ovary:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carcinoid tumors is a germ cell tumor, primarily produce serotonin and do not typically cause virilization.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Theca cell tumor:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Theca cell tumors are sex xord tumours and can produce estrogen, not androgens.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arrhenoblastoma is a virilizing ovarian tumor known for its androgen production, often leading to masculinizing symptoms in females.</span></span></span></p>",
      "correct_choice_id": 175692,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56995,
      "choices": [
        {
          "id": 227369,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Turner syndrome</span></span></span></p>"
        },
        {
          "id": 227370,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Klinefelter syndrome</span></span></span></p>"
        },
        {
          "id": 227371,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Down syndrome</span></span></span></p>"
        },
        {
          "id": 227372,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Partial mole</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">15-year-old girl with wide-spaced nipples, short height, and the following karyotype: (NEET PG 2024)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-121812.jpg\" style=\"height:235px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q9545211",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771242,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A) Turner syndrome</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Turner syndrome is a genetic condition characterized by the presence of only one X chromosome (45, X) rather than the typical two sex chromosomes (XX or XY). The karyotype shown confirms the absence of the Y chromosome and only one X chromosome, which is diagnostic of Turner syndrome. Clinical features often include short stature, wide-spaced nipples, webbed neck, and other physical anomalies. Turner syndrome is a common genetic condition tested in exams due to its distinctive features and significant clinical implications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Klinefelter syndrome:</span></strong><span style=\"font-size:12.0pt\"> Klinefelter syndrome is a genetic condition characterized by the presence of an extra X chromosome in males (47, XXY). It does not fit the description of a 15-year-old girl with the specific karyotype shown and is not associated with the physical characteristics described.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Down syndrome:</span></strong><span style=\"font-size:12.0pt\"> Down syndrome is characterized by trisomy 21 (an extra chromosome 21) and typically presents with distinct facial features, intellectual disability, and other health issues. The karyotype shown does not match Down syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Partial mole:</span></strong><span style=\"font-size:12.0pt\"> A partial mole is a type of gestational trophoblastic disease involving an abnormal pregnancy with an extra set of paternal chromosomes, often presenting with symptoms related to pregnancy and abnormal placental tissue rather than the clinical features described here.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Turner syndrome is characterized by the karyotype 45,X, and typical clinical features include short stature and wide-spaced nipples, commonly seen in females.</span></span></span></p>",
      "correct_choice_id": 227369,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74700,
      "choices": [
        {
          "id": 297713,
          "text": "<p><span style=\"font-size:16px;\">Fasting Hypoglycemia and Postprandial Hyperglycemia</span></p>"
        },
        {
          "id": 297714,
          "text": "<p><span style=\"font-size:16px;\">Increase SBP and DBP at 6 weeks</span></p>"
        },
        {
          "id": 297715,
          "text": "<p><span style=\"font-size:16px;\">Increase in RBC mass</span></p>"
        },
        {
          "id": 297716,
          "text": "<p><span style=\"font-size:16px;\">Peripheral Insulin Resistance</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Physiological changes in pregnancy include all of the following except: (INICET NOV 2024)</span></p>",
      "unique_key": "Q9125782",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770827,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Increase in SBP and DBP at 6 weeks</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">During pregnancy, blood pressure decreases throughout pregnancy, with the maximum fall occurring in the second trimester. This is a normal physiological adaptation. An increase in blood pressure (<strong>either systolic or diastolic</strong>) is <strong>not a normal physiological change and could indicate a pathological condition like preeclampsia.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Fasting Hypoglycemia and Postprandial Hyperglycemia:&nbsp;</strong>This is incorrect as this is a normal physiological change in pregnancy. Pregnant women experience fasting hypoglycemia and postprandial hyperglycemia as part of normal pregnancy adaptation.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Increase in RBC mass:&nbsp;</strong>This is incorrect as this is a normal physiological change. During pregnancy, there is an increase in RBC mass, although the increase in plasma volume is proportionally greater, leading to physiological anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Peripheral Insulin Resistance</strong>: This is incorrect as this is a normal physiological change. Pregnancy is characterized by increased peripheral insulin resistance, which puts women at higher risk of developing gestational diabetes mellitus.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p><br><span style=\"font-size:16px;\">Blood pressure normally <strong>decreases during pregnancy</strong>, with maximum fall in the second trimester. Any increase in blood pressure during pregnancy is abnormal and requires evaluation.</span></p>",
      "correct_choice_id": 297714,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56945,
      "choices": [
        {
          "id": 227169,
          "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-12-13%20142711.jpg\" width=\"319\" height=\"224\"></p>"
        },
        {
          "id": 227170,
          "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-12-13%20142726.jpg\" width=\"345\" height=\"227\"></p>"
        },
        {
          "id": 227171,
          "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-12-13%20142739_8OcHaVT.jpg\" width=\"313\" height=\"222\"></p>"
        },
        {
          "id": 227172,
          "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-12-13%20142801.jpg\" width=\"325\" height=\"215\"></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The type of pelvis commonly associated with occipitoposterior and face to pubis is: (NEET PG 2024)</span></p>",
      "unique_key": "Q2274895",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771232,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)</strong></span><span style=\"font-size:11pt;\">&nbsp;</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-12-13%20142739.jpg\" width=\"313\" height=\"222\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The anthropoid pelvis is characterized by a larger anteroposterior diameter compared to its transverse diameter, giving it a vertical oval shape. This type of pelvis is commonly associated with occipitoposterior positions and the \"face to pubis\" delivery pattern, where the baby's face presents toward the pubic symphysis during delivery. The anthropoid shape often causes the baby's head to rotate into a posterior position, leading to a higher likelihood of occipitoposterior presentations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Gynecoid pelvis:</strong> The gynecoid pelvis is the typical female pelvis with a round shape and balanced anteroposterior and transverse diameters. It is most favorable for vaginal deliveries and is not commonly associated with occipitoposterior positions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Android pelvis:</strong> The android pelvis is heart-shaped, narrower, and typically has prominent ischial spines. It is more commonly associated with obstructed labor and deep transverse arrest rather than occipitoposterior or face to pubis presentations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Platypelloid pelvis:</strong> The platypelloid pelvis is characterized by a very wide transverse diameter and a flat shape, which often leads to delayed engagement of the fetal head. It is not associated with occipitoposterior positions but can lead to asynclitism and face presentations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The anthropoid pelvis is the pelvic type most commonly associated with occipitoposterior positions and the \"face to pubis\" delivery pattern.</span></p>",
      "correct_choice_id": 227171,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20494,
      "choices": [
        {
          "id": 81938,
          "text": "<p><span style=\"font-size:12pt;\">Cesarean section</span></p>"
        },
        {
          "id": 81939,
          "text": "<p><span style=\"font-size:12pt;\">External cephalic version</span></p>"
        },
        {
          "id": 81940,
          "text": "<p><span style=\"font-size:12pt;\">Expectant management</span></p>"
        },
        {
          "id": 81941,
          "text": "<p><span style=\"font-size:12pt;\">Induction of labor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old pregnant G3P2L2 woman presented to OBG department at 36 weeks of amenorrhea. Ultrasound shows that the fetus is in a transverse lie. The liquor is adequate, the placenta is normal, and she has no gross anomaly. Both her previous deliveries were normal vaginal deliveries. How will you manage this patient? (NEET PG 2023)</span></p>",
      "unique_key": "Q7097710",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771256,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) External cephalic version</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In this situation, external cephalic version should be attempted.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Management of Transverse lie –</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/10/screenshot-2024-08-10-181609.png\" alt=\"\" width=\"1000\" height=\"234\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Absolute Contraindications of ECV:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Placenta Previa</span></li><li><span style=\"font-size:12pt;\">Contracted Pelvis</span></li><li><span style=\"font-size:12pt;\">Multiple Pregnancy</span></li><li><span style=\"font-size:12pt;\">Hyperextended head</span></li><li><span style=\"font-size:12pt;\">Uterine Anomaly</span></li><li><span style=\"font-size:12pt;\">Dead fetus</span></li><li><span style=\"font-size:12pt;\">Distressed fetus</span></li><li><span style=\"font-size:12pt;\">Denied consent</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Complications of ECV:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Abruption</span></li><li><span style=\"font-size:12pt;\">Rupture of membranes</span></li><li><span style=\"font-size:12pt;\">Preterm labour.</span></li><li><span style=\"font-size:12pt;\">Fetal distress.</span></li><li><span style=\"font-size:12pt;\">Cord presentation or prolapse</span></li><li><span style=\"font-size:12pt;\">Entangling of the cord around the fetus.</span></li><li><span style=\"font-size:12pt;\">Isoimmunization in Rh-negative mothers due to feto-maternal transfusion.</span></li><li><span style=\"font-size:12pt;\">Induction of labor is contraindicated in Transverse lie.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Cesarean section:</strong> While a cesarean section is the best and safest method of delivery in cases of persistent transverse or oblique lie, it is not the first-line management in this situation where ECV can be attempted.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Expectant management:</strong> Waiting for spontaneous correction is not recommended at 36 weeks with a transverse lie, as it may not occur, and could lead to complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Induction of labor:</strong> Inducing labor in a transverse lie position is contraindicated as it can lead to complications such as cord prolapse and obstructed labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">External cephalic version should be attempted between 36 and 37 weeks of gestation for a fetus in a transverse lie if there are no contraindications.</span></p>",
      "correct_choice_id": 81939,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56953,
      "choices": [
        {
          "id": 227201,
          "text": "<p><span style=\"font-size:12.0pt;\">Warfarin</span></p>"
        },
        {
          "id": 227202,
          "text": "<p><span style=\"font-size:12.0pt;\">LMWH (Low Molecular Weight Heparin)</span></p>"
        },
        {
          "id": 227203,
          "text": "<p><span style=\"font-size:12.0pt;\">Fondaparinux</span></p>"
        },
        {
          "id": 227204,
          "text": "<p><span style=\"font-size:12.0pt;\">Apixaban</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old woman in her second pregnancy is diagnosed with deep vein thrombosis (DVT) at 30 weeks gestation. What is the drug of choice for her treatment?&nbsp;(NEET PG 2024)</span></p>",
      "unique_key": "Q7786045",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771234,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) LMWH (Low Molecular Weight Heparin)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Low Molecular Weight Heparin (LMWH)</strong>. LMWH is the preferred treatment for deep vein thrombosis (DVT) during pregnancy due to its safety profile and ease of monitoring. LMWH does not cross the placenta, making it safer for the fetus compared to other anticoagulants. Additionally, LMWH requires less frequent monitoring compared to unfractionated heparin, making it more convenient for both patients and healthcare providers during pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Warfarin</strong>: Warfarin is <strong>contraindicated in pregnancy</strong> because it crosses the placenta and can lead to fetal complications, including congenital malformations and bleeding. Warfarin is generally reserved for patients with specific conditions such as mechanical heart valves who were already on the drug before pregnancy, under careful supervision.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Fondaparinux</strong>: While Fondaparinux is an anticoagulant, it is not the first-line choice for DVT in pregnancy. <strong>It is generally considered when LMWH is contraindicated</strong>, such as in cases of heparin-induced thrombocytopenia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Apixaban</strong>: Apixaban, a direct oral anticoagulant (DOAC), is not recommended in pregnancy due to insufficient safety data. DOACs are <strong>generally avoided during pregnancy</strong> because they can cross the placenta and pose risks to the fetus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In pregnancy, the drug of choice for treating DVT is Low Molecular Weight Heparin (LMWH) due to its safety and ease of monitoring compared to other anticoagulants</span></p>",
      "correct_choice_id": 227202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74679,
      "choices": [
        {
          "id": 297629,
          "text": "<p><span style=\"font-size:16px;\">5%</span></p>"
        },
        {
          "id": 297630,
          "text": "<p><span style=\"font-size:16px;\">10%</span></p>"
        },
        {
          "id": 297631,
          "text": "<p><span style=\"font-size:16px;\">15%</span></p>"
        },
        {
          "id": 297632,
          "text": "<p><span style=\"font-size:16px;\">20%</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A couple has been attempting to conceive for the past two years with unprotected intercourse yet without success, the husband's semen analysis was ordered and results are as follows:&nbsp;</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Volume: 2ml</span></li><li><span style=\"font-size:16px;\">Viability: 75%</span></li><li><span style=\"font-size:16px;\">Sperm count: 40 million per ejaculate</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">The wife’s HSG report shows no abnormalities. What percentage of infertile women have unexplained infertility? (INICET NOV 2024)</span></p>",
      "unique_key": "Q5347856",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770715,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) 15%</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In cases of infertility, the distribution of causes follows a specific pattern:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Female factor infertility: 40%</strong></span></li><li><span style=\"font-size:16px;\"><strong>Male factor infertility: 30%</strong></span></li><li><span style=\"font-size:16px;\"><strong>Combined male and female factors: 15%</strong></span></li><li><span style=\"font-size:16px;\"><strong>Unexplained infertility: 15%</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">Unexplained infertility is diagnosed when:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Standard fertility tests are <strong>normal</strong></span></li><li><span style=\"font-size:16px;\">No obvious cause is identified despite thorough evaluation</span></li><li><span style=\"font-size:16px;\">Tests showing normal results include:&nbsp;</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\"><strong>Ovulation tests</strong></span></li><li><span style=\"font-size:16px;\"><strong>Tubal patency (HSG)</strong></span></li><li><span style=\"font-size:16px;\"><strong>Uterine cavity evaluation</strong></span></li><li><span style=\"font-size:16px;\"><strong>Semen analysis</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Unexplained infertility accounts for 15% of all infertility cases, while female factor accounts for 40%, male factor for 30%, and combined factors for 15%.</span></p>",
      "correct_choice_id": 297631,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56970,
      "choices": [
        {
          "id": 227269,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Radiologist</span></span></span></p>"
        },
        {
          "id": 227270,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gynecologist</span></span></span></p>"
        },
        {
          "id": 227271,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Legal advisor</span></span></span></p>"
        },
        {
          "id": 227272,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pediatrician</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">All are the members of the medical board in MTP &gt; 24 weeks, except?&nbsp;</span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2024)</span></span></p>",
      "unique_key": "Q1305336",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771239,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Legal advisor</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For medical termination of pregnancy (MTP) after 24 weeks, especially in cases of substantial fetal anomalies, a medical board is constituted. This board typically includes specialists relevant to the condition and the required medical care. The standard members include: <strong>Radiologist, Gynecologist and Pediatrician. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A legal advisor is not a part of this medical board, as the board&#39;s purpose is to provide medical, not legal, expertise. The fourth member is often a specialist relevant to the detected anomaly rather than a legal professional.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Radiologist:</span></strong><span style=\"font-size:12.0pt\"> Included to assess fetal abnormalities through imaging and provide critical information about the anomaly.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Gynecologist:</span></strong><span style=\"font-size:12.0pt\"> A core member who handles the MTP procedure and provides obstetric and gynecological care.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Pediatrician:</span></strong><span style=\"font-size:12.0pt\"> Included to give an opinion on the implications of fetal anomalies and expected postnatal outcomes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In MTP cases beyond 24 weeks, the medical board consists of medical professionals such as radiologists, gynecologists, and pediatricians, but not legal advisors.</span></span></span></p>",
      "correct_choice_id": 227271,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74698,
      "choices": [
        {
          "id": 297705,
          "text": "<p><span style=\"font-size:16px;\">Head sheath</span></p>"
        },
        {
          "id": 297706,
          "text": "<p><span style=\"font-size:16px;\">Connecting part</span></p>"
        },
        {
          "id": 297707,
          "text": "<p><span style=\"font-size:16px;\">Middle piece</span></p>"
        },
        {
          "id": 297708,
          "text": "<p><span style=\"font-size:16px;\">Tail</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Mitochondria of spermatozoa form the: (INICET NOV 2024)</span></p>",
      "unique_key": "Q7184860",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770826,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Middle piece</strong></span></p><p><br><span style=\"font-size:16px;\">The mitochondria of spermatozoa are specifically located in the <strong>middle piece of the sperm</strong>. The middle piece contains numerous mitochondria arranged in a <strong>helical pattern around the axoneme.</strong> These mitochondria are essential for providing the energy required for sperm motility through ATP production.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_wyJ3Q6J.png\" width=\"577\" height=\"609\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options</strong>:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Head sheath:&nbsp;</strong>Incorrect because the head contains the nucleus and acrosome, not mitochondria&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Connecting part:&nbsp;</strong>Incorrect as it's just a transitional region&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Tail:&nbsp;</strong>Incorrect as the tail (principal piece and end piece) contains the axoneme and outer dense fibers but no mitochondria</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p><br><span style=\"font-size:16px;\">The mitochondria of spermatozoa are specifically located in the middle piece, providing energy for sperm motility.</span></p>",
      "correct_choice_id": 297707,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20489,
      "choices": [
        {
          "id": 81918,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chlamydial infection</span></span></span></p>"
        },
        {
          "id": 81919,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bartholin abscess</span></span></span></p>"
        },
        {
          "id": 81920,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Genital Tuberculosis</span></span></span></p>"
        },
        {
          "id": 81921,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Herpes infection</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman comes with complaints of pain and swelling in the perineal area, difficulty in walking and sitting. She has a history of multiple sexual partners. On examination, a tender swelling is seen with redness on the labia, as shown in the image given below. What is the most likely diagnosis?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">(NEET PG 2023)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/whatsapp-image-2023-06-12-at-1901210148.jpg\" style=\"height:347px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q8813056",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771253,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Bartholin abscess</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given clinical scenario and image points to the diagnosis of Bartholin&#39;s abscess.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bartholin Cyst and Abscess</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bartholin gland is a mucus-secreting gland, which plays a role in vaginal lubrication. They are a pair of 0.5 cm glands located in the lower right and left portions at the 4 o&rsquo;clock and 8 o&rsquo;clock positions of the vaginal introitus. They are generally nonpalpable when not obstructed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pathophysiology: Bartholin glands can form a cyst and an abscess in women of reproductive age and may cause dyspareunia, urinary irritation, and vague pelvic pain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The physical exam will often reveal asymmetry with a protrusion of one side (left or right) of the inferior aspect of the vulva.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bartholin gland abscesses, unlike Bartholin cysts, are very painful.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While both are primarily unilateral, Bartholin abscesses are often tender to palpation, erythematous, indurated, and may have an area of fluctuance and/or purulent drainage.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asymptomatic Bartholin cysts do not require further treatment.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bartholin abscesses may be treated with incision and drainage with Word catheter placement due to ease and effectiveness of treatment.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Marsupialization is the procedure of choice.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Women with recurrent cysts or those who are post-menopausal (risk of malignancy) should have the cyst completely excised.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Chlamydial infection</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Chlamydial infection patient usually present with vaginal discharge, dysuria, or cervicitis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Genital tuberculosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Genital tuberculosis involves the upper genital tract, leading to menstrual irregularities, infertility, and abdominal pain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Genital herpes</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Genital herpes usually presents as painful ulcers or vesicles in the genital area, rather than a tender, erythematous swelling.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A Bartholin abscess presents with significant pain, redness, and swelling in the labia, often making walking and sitting difficult.</span></span></span></p>",
      "correct_choice_id": 81919,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44012,
      "choices": [
        {
          "id": 175707,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Emergency LSCS</span></span></span></p>"
        },
        {
          "id": 175708,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start Antihypertensives and emergency LSCS</span></span></span></p>"
        },
        {
          "id": 175709,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start Antihypertensives and ARM</span></span></span></p>"
        },
        {
          "id": 175710,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tocolysis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pregnant woman at 30 weeks presents with painful bleeding PV, reduced fetal movement, increased uterine tone, and absent FHR. BP is 166/98 mmHg, and the cervix is 6cm dilated, 70% effaced with intact membranes. What is the next best step?&nbsp;</span></span></span>(INICET NOV 2023)</p>",
      "unique_key": "Q2651506",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770397,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Start Antihypertensives and ARM</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Given the high BP and symptoms suggesting placental issues, starting antihypertensives addresses the hypertension, and artificial rupture of membranes (ARM) is indicated to advance labor, especially in a context where continuing pregnancy may pose risks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Emergency LSCS:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> An emergency LSCS without addressing hypertension could be risky.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Start Antihypertensives and emergency LSCS:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While emergency surgery is critical, managing BP first is essential.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Tocolysis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Tocolysis is contraindicated in hypertensive disorders and fetal distress.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cases of hypertensive crisis with placental issues, managing maternal BP is crucial before procedures like ARM to safely advance labor.</span></span></span></p>",
      "correct_choice_id": 175709,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20487,
      "choices": [
        {
          "id": 81910,
          "text": "<p><span style=\"font-size:12pt;\">Oral methotrexate</span></p>"
        },
        {
          "id": 81911,
          "text": "<p><span style=\"font-size:12pt;\">Single-dose methotrexate injection</span></p>"
        },
        {
          "id": 81912,
          "text": "<p><span style=\"font-size:12pt;\">Serial methotrexate + leucovorin rescue</span></p>"
        },
        {
          "id": 81913,
          "text": "<p><span style=\"font-size:12pt;\">Salpingectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female presents to OPD with 6 weeks of amenorrhea complaints of bleeding per vagina and mild abdominal pain. The urine pregnancy test is positive and hCG level is 2800 IU/L. On investigation, mass is seen on the left adnexa measuring 3 x 2 cm. She is hemodynamically stable. How will you manage this patient?&nbsp;(NEET PG 2023)</span></p>",
      "unique_key": "Q8338569",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771252,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Single-dose methotrexate injection</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The clinical scenario presented indicates an unruptured ectopic pregnancy. The patient is hemodynamically stable, and the hCG level is 2800 IU/L with an adnexal mass measuring 3 x 2 cm. These findings meet the criteria for medical management of an ectopic pregnancy with methotrexate. Single-dose methotrexate injection is an appropriate treatment choice for an unruptured ectopic pregnancy when the patient is stable, has no significant symptoms, and the gestational sac is less than 3.5 cm in size without visible cardiac activity. Methotrexate is a folic acid antagonist that inhibits DNA synthesis and cell replication, effectively treating the ectopic pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Oral methotrexate:</strong> Oral methotrexate is not a standard treatment protocol for ectopic pregnancy. Methotrexate for ectopic pregnancy is typically administered via injection to ensure proper dosage and effectiveness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Serial methotrexate + leucovorin rescue:</strong> This multidose protocol is used for ectopic pregnancies with higher hCG levels or when the single-dose protocol is contraindicated or has failed. However, it is more complex and involves multiple injections and monitoring.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Salpingectomy:</strong> Surgical management, such as salpingectomy, is indicated for ectopic pregnancies with significant pain, adnexal masses larger than 35 mm, visible fetal heartbeat, or serum hCG levels of 5000 IU/L or more. In this case, the patient’s condition does not meet these criteria, making surgery unnecessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Management of Unruptured Ectopic</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/10/screenshot-2024-08-10-180854.png\" alt=\"\" width=\"1000\" height=\"577\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Surgical Management in Unruptured Ectopic –</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Indicated in:</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-roman;\"><li><span style=\"font-size:12pt;\">an ectopic pregnancy and significant pain</span></li><li><span style=\"font-size:12pt;\">an ectopic pregnancy with an adnexal mass of 35 mm or larger</span></li><li><span style=\"font-size:12pt;\">an ectopic pregnancy with a fetal heartbeat visible on an ultrasound scan</span></li><li><span style=\"font-size:12pt;\">an ectopic pregnancy and a serum hCG level of 5,000 IU/L or more</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\">&nbsp;Laparoscopy is preferred</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">SALPINGECTOMY: Preferred if:</span><ul><li><span style=\"font-size:12pt;\">Extensive tubal involvement/ damage</span></li><li><span style=\"font-size:12pt;\">Recurrent ectopic pregnancy in the same tube</span></li><li><span style=\"font-size:12pt;\">Completed family</span></li><li><span style=\"font-size:12pt;\">Ectopic at the site of a previous tubal sterilization</span></li></ul></li><li><span style=\"font-size:12pt;\">SALPINGOSTOMY: (Linear incision on the antimesenteric border with removal of products of conception) Done if a woman wants to conceive in the future.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The management of an unruptured ectopic pregnancy in a hemodynamically stable patient with an hCG level less than 5000 IU/L and an adnexal mass smaller than 3.5 cm is typically treated with a single-dose methotrexate injection.</span></p>",
      "correct_choice_id": 81911,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74677,
      "choices": [
        {
          "id": 297621,
          "text": "<p><span style=\"font-size:16px;\">Before 28 weeks</span></p>"
        },
        {
          "id": 297622,
          "text": "<p><span style=\"font-size:16px;\">Before 30 weeks</span></p>"
        },
        {
          "id": 297623,
          "text": "<p><span style=\"font-size:16px;\">Before 32 weeks</span></p>"
        },
        {
          "id": 297624,
          "text": "<p><span style=\"font-size:16px;\">Before 34 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Early onset pre-eclampsia is defined as: (INICET NOV 2024)</span></p>",
      "unique_key": "Q8850819",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770503,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Before 34 weeks</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Early onset pre-eclampsia is defined as pre-eclampsia that develops <strong>before 34 weeks</strong> of gestation.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Early onset pre-eclampsia:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Indicates potentially <strong>higher severity</strong></span></li><li><span style=\"font-size:16px;\">Is associated with conditions like <strong>antiphospholipid antibody syndrome</strong></span></li><li><span style=\"font-size:16px;\">Can be prevented by <strong>administering low-dose aspirin</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Early onset pre-eclampsia is defined as pre-eclampsia occurring <strong>before 34 weeks of gestation</strong>, while late-onset pre-eclampsia occurs <strong>after 34 weeks.</strong></span></p>",
      "correct_choice_id": 297624,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57001,
      "choices": [
        {
          "id": 227393,
          "text": "<p><span style=\"font-size:12.0pt;\">Superfecundation</span></p>"
        },
        {
          "id": 227394,
          "text": "<p><span style=\"font-size:12.0pt;\">Superfetation</span></p>"
        },
        {
          "id": 227395,
          "text": "<p><span style=\"font-size:12.0pt;\">Illegitimate</span></p>"
        },
        {
          "id": 227396,
          "text": "<p><span style=\"font-size:12.0pt;\">Monochorionic monoamniotic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Twin pregnancy where 1 twin is older by 1 month than the other on ultrasound. What is this known as? (NEET PG 2024)</span></p>",
      "unique_key": "Q4371285",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771245,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B) Superfetation</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Superfetation is the phenomenon where two ova are released in separate menstrual cycles and are fertilized at different times, leading to the conception of twins with different gestational ages. This means that one twin is conceived at a later date than the other, which can result in an observable difference in size or developmental stage on ultrasound. Although superfetation is documented in some animals, it is extremely rare and largely theoretical in humans due to the cessation of ovulation after the first conception. Nonetheless, it is the best explanation for the scenario where one twin appears to be older by a month than the other.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Superfecundation:&nbsp;</strong>Superfecundation occurs when two ova released in the same menstrual cycle are fertilized by separate acts of intercourse. <strong>The twins conceived have the same gestational age</strong>, although they may vary slightly in size. This phenomenon does not explain a one-month difference in age between twins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Illegitimate:&nbsp;</strong>This term is not a medical explanation related to twin pregnancies. It refers to a non-scientific or socially defined concept and does not pertain to any biological condition involving twins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Monochorionic monoamniotic:&nbsp;</strong>This refers to twins that share both the chorion and the amniotic sac, resulting from the splitting of <strong>a single fertilized egg</strong>. These twins are identical and have the same gestational age; they do not account for any significant size or age discrepancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Superfetation refers to a rare phenomenon where twins are conceived at different times, resulting in a significant difference in gestational ages, although it is mostly theoretical in humans.</span></p>",
      "correct_choice_id": 227394,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6130,
      "choices": [
        {
          "id": 24489,
          "text": "<p><span style=\"font-size:12pt;\">B, A, C, D</span></p>"
        },
        {
          "id": 24490,
          "text": "<p><span style=\"font-size:12pt;\">B, A, D, C</span></p>"
        },
        {
          "id": 24491,
          "text": "<p><span style=\"font-size:12pt;\">B, C, A, D</span></p>"
        },
        {
          "id": 24492,
          "text": "<p><span style=\"font-size:12pt;\">B, D, A, C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Arrange the following in sequence?&nbsp;</span>(INICET NOV 2022)</p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12pt;\">Crowning</span></li><li><span style=\"font-size:12pt;\">Engagement</span></li><li><span style=\"font-size:12pt;\">Restitution</span></li><li><span style=\"font-size:12pt;\">External rotation</span></li></ol>",
      "unique_key": "Q3546784",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770391,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) B, A, C, D</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The sequence of cardinal movements in the mechanism of labor is a series of positions and motions that the fetus goes through as it navigates through the birth canal. These movements are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Engagement</strong>: This is when the fetal head enters the pelvic inlet and the widest part of the head has passed through the pelvic brim.</span></li><li><span style=\"font-size:12pt;\"><strong>Descent</strong>: The downward movement of the fetal head within the pelvic inlet.</span></li><li><span style=\"font-size:12pt;\"><strong>Flexion</strong>: The fetal head bends so the chin is brought closer to the chest, presenting the smallest diameter to the birth canal.</span></li><li><span style=\"font-size:12pt;\"><strong>Internal Rotation</strong>: The fetal head rotates to align with the maternal pelvis.</span></li><li><span style=\"font-size:12pt;\"><strong>Crowning</strong>: The fetal head is visible at the vulva without slipping back.</span></li><li><span style=\"font-size:12pt;\"><strong>Extension</strong>: The fetal head extends as it passes under the symphysis pubis.</span></li><li><span style=\"font-size:12pt;\"><strong>Restitution</strong>: The fetal head rotates to the position it was in when it engaged in the pelvis.</span></li><li><span style=\"font-size:12pt;\"><strong>External Rotation</strong>: The fetal shoulders rotate to align with the head.</span></li><li><span style=\"font-size:12pt;\"><strong>Expulsion of the rest of the body</strong>: The remainder of the fetal body is delivered.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. B, A, D, C</strong>: This sequence incorrectly places external rotation before restitution.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. B, C, A, D</strong>: This sequence incorrectly places restitution before crowning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. B, D, A, C</strong>: This sequence incorrectly places external rotation before crowning and restitution.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The cardinal movements in the mechanism of labor occur in the following sequence: engagement, descent, flexion, internal rotation, extension (preceded by crowning), restitution, external rotation, and expulsion of the rest of the body.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg 145</strong></span></p>",
      "correct_choice_id": 24489,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6127,
      "choices": [
        {
          "id": 24477,
          "text": "<p><span style=\"font-size:12pt;\">Vulval dystrophy</span></p>"
        },
        {
          "id": 24478,
          "text": "<p><span style=\"font-size:12pt;\">Vulval hamartoma</span></p>"
        },
        {
          "id": 24479,
          "text": "<p><span style=\"font-size:12pt;\">Smoking</span></p>"
        },
        {
          "id": 24480,
          "text": "<p><span style=\"font-size:12pt;\">Vulval warts</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">All of the following are risk factors of vulval cancer except?&nbsp;</span>(INICET NOV 2022)</p>",
      "unique_key": "Q9876012",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770389,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Vulval hamartoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Vulval cancer has several known risk factors, which include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Chronic vulval irritation</strong>: Persistent irritation and inflammation can contribute to the development of vulval cancer.</span></li><li><span style=\"font-size:12pt;\"><strong>Immunosuppressive conditions</strong>: Conditions such as pregnancy and HIV infection can compromise the immune system, increasing the risk of vulval cancer.</span></li><li><span style=\"font-size:12pt;\"><strong>HPV (Human Papillomavirus)</strong>: Infection with HPV, particularly strains 16 and 18, is a significant risk factor.</span></li><li><span style=\"font-size:12pt;\"><strong>Smoking</strong>: Smoking is a known risk factor for various cancers, including vulval cancer.</span></li><li><span style=\"font-size:12pt;\"><strong>Condyloma (anogenital warts)</strong>: Caused by HPV, these warts can lead to changes in vulval cells that may progress to cancer.</span></li><li><span style=\"font-size:12pt;\"><strong>Sexually transmitted diseases (STDs)</strong>: History of STDs can increase the risk due to the association with HPV and chronic inflammation.</span></li><li><span style=\"font-size:12pt;\"><strong>Vulvar dystrophies</strong>: Conditions like lichen sclerosus can predispose individuals to vulval cancer.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Vulval hamartoma</strong> is not a risk factor for vulval cancer. Hamartomas are benign, disorganized clusters of tissue that do not typically transform into malignant tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Vulval dystrophy</strong>: Vulval dystrophies, such as lichen sclerosus, are risk factors for vulval cancer due to chronic irritation and inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Smoking</strong>: Smoking is a well-documented risk factor for many cancers, including vulval cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Vulval warts</strong>: Vulval warts, often caused by HPV, can lead to cellular changes that increase the risk of vulval cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Vulval hamartomas are not a risk factor for vulval cancer, while chronic irritation, immunosuppressive conditions, HPV infection, smoking, anogenital warts, STDs, and vulvar dystrophies are known risk factors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of gynecology 3<sup>rd</sup> edition pg 680, Dutta’s textbook of gynecology 6<sup>th</sup> edition pg 334</strong></span></p>",
      "correct_choice_id": 24478,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56959,
      "choices": [
        {
          "id": 227225,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LBC + HPV + cervical biopsy</span></span></p>"
        },
        {
          "id": 227226,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pap smear + HCV</span></span></p>"
        },
        {
          "id": 227227,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pap smear + HBV</span></span></p>"
        },
        {
          "id": 227228,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VDRL + HBV</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman with a history of cervical erosion and spotting since 2 months. What is the next best step?&nbsp;(NEET PG 2024)</span></span></p>",
      "unique_key": "Q3074186",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771236,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A)&nbsp; LBC + HPV + cervical biopsy</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is a 45-year-old woman presenting with cervical erosion and spotting, which raises a concern for potential cervical cancer. In such cases, the next best step involves a comprehensive approach to screen for cervical cancer:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Liquid-based cytology (LBC):</span></strong><span style=\"font-size:12.0pt\"> This test is used to detect abnormal cells in the cervix.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">HPV testing:</span></strong><span style=\"font-size:12.0pt\"> This helps identify high-risk human papillomavirus strains that are associated with cervical cancer.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Cervical biopsy:</span></strong><span style=\"font-size:12.0pt\"> If any abnormalities are found on cytology or HPV testing, a cervical biopsy can confirm the diagnosis.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Performing all three tests together provides a thorough evaluation, as cervical cancer screening is essential in women presenting with these symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Pap smear + HCV:</span></strong><span style=\"font-size:12.0pt\"> While a Pap smear is appropriate for screening, HCV (Hepatitis C Virus) testing is unrelated to the current presentation of cervical symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Pap smear + HBV:</span></strong><span style=\"font-size:12.0pt\"> Similar to option B, the Pap smear is correct, but testing for HBV (Hepatitis B Virus) does not address the concern for cervical cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. VDRL + HBV:</span></strong><span style=\"font-size:12.0pt\"> VDRL is used for syphilis screening and is not relevant to cervical erosion and spotting, nor is HBV testing in this context.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For a patient with cervical erosion and spotting, the best approach is to screen for cervical cancer with LBC, HPV testing, and a cervical biopsy if indicated.</span></span></span></p>",
      "correct_choice_id": 227225,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56832,
      "choices": [
        {
          "id": 226721,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Do ultrasound for gestational age, check for abnormalities, check sex, and tell the mother.</span></span></span></p>"
        },
        {
          "id": 226722,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Do ultrasound for gestational age, check for abnormalities, check sex but don&rsquo;t tell the mother.</span></span></span></p>"
        },
        {
          "id": 226723,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Do ultrasound for gestational age, check for abnormalities, don&rsquo;t check the sex.</span></span></span></p>"
        },
        {
          "id": 226724,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Don&rsquo;t do ultrasound, do ANC only.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old G5L4 with all 4-girl children presents at 18 weeks and asks for the sex of the child on ultrasound. This is her first antenatal visit. What should be done? (NEET PG 2024)</span></span></p>",
      "unique_key": "Q7138820",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770833,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Do ultrasound for gestational age, check for abnormalities, don&rsquo;t check the sex.</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Ans<strong>.</strong> is C because, according to the Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act, sex determination of the fetus is illegal and punishable by law. At 18 weeks, the primary purpose of the ultrasound is to assess gestational age and check for any fetal abnormalities as part of the anomaly scan. Checking or revealing the sex of the fetus is prohibited and carries legal consequences. Therefore, the healthcare provider should perform the ultrasound for the medical purposes it is intended for and avoid even viewing the sex of the fetus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Do ultrasound for gestational age, check for abnormalities, check sex, and tell the mother:</strong> is incorrect because checking the sex and informing the mother is illegal under the PCPNDT Act, and can lead to legal repercussions, including imprisonment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Do ultrasound for gestational age, check for abnormalities, check sex but don&rsquo;t tell the mother:</strong> is also incorrect. Even looking at the fetus&rsquo;s sex, regardless of whether it is disclosed, is a violation of the law and is punishable.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Don&rsquo;t do ultrasound, do ANC only:</strong> is incorrect because the ultrasound at 18 weeks is necessary for evaluating gestational age and detecting any fetal abnormalities, which are critical aspects of prenatal care.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The key point to remember is that checking or revealing the sex of the fetus during an ultrasound is illegal under the PCPNDT Act. The ultrasound should only be used for assessing fetal gestational age and abnormalities.</span></span></p>",
      "correct_choice_id": 226723,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74703,
      "choices": [
        {
          "id": 297725,
          "text": "<p><span style=\"font-size:12.0pt;\">Pap smear alone every 5 yearly</span></p>"
        },
        {
          "id": 297726,
          "text": "<p><span style=\"font-size:12.0pt;\">Pap smear + HPV DNA every 5 yearly</span></p>"
        },
        {
          "id": 297727,
          "text": "<p><span style=\"font-size:12.0pt;\">Pap smear alone every 3 yearly</span></p>"
        },
        {
          "id": 297728,
          "text": "<p><span style=\"font-size:12.0pt;\">Pap smear in high-risk individuals</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Dr. Savita is posted in a low-resource hospital setting. She explains to a patient about risk factors of cervical cancer, including HPV. Which of the following would be appropriate for cervical cancer screening? (INICET NOV 2024)</span></p>",
      "unique_key": "Q1287013",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770828,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Pap smear alone every 3 yearly</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In a low-resource hospital setting, <strong>Pap smear alone every 3 years</strong> is the most appropriate screening method for cervical cancer. The screening should begin at <strong>age 21 years</strong> (some guidelines recommend 25 years). While HPV testing has become the <strong>method of choice&nbsp;</strong>in many updated guidelines, in resource-limited settings, <strong>Pap smear</strong> remains the primary screening tool due to its <strong>cost-effectiveness and established infrastructure</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Pap smear alone every 5 yearly: </strong>Incorrect because the recommended interval for Pap smear screening is 3 years, not 5 years. Five-yearly screening is appropriate for HPV testing or co-testing.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Pap smear + HPV DNA every 5 yearly:&nbsp;</strong>Incorrect because while co-testing is an acceptable method, it increases costs and is not the method of choice in low-resource settings. This option would unnecessarily increase the financial burden.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Pap smear in high-risk individuals:&nbsp;</strong>Incorrect because cervical cancer screening should be done in all eligible women, not just high-risk individuals. Universal screening is essential for effective prevention.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In low-resource settings, cervical cancer screening should be done using <strong>Pap smear alone every 3 years, starting from age 21 years</strong>.</span></p>",
      "correct_choice_id": 297727,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56931,
      "choices": [
        {
          "id": 227113,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Endometriosis</span></span></span></p>"
        },
        {
          "id": 227114,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Fibroids</span></span></span></p>"
        },
        {
          "id": 227115,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Sarcoidosis</span></span></span></p>"
        },
        {
          "id": 227116,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Genital TB</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 25-year-old woman whose last delivery was 5 years back presents with secondary amenorrhea of 2 years. She does not bleed on giving estrogen and progesterone. A laparoscopy shows the following. What is the diagnosis? (NEET PG 2024)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-121347.jpg\" style=\"height:242px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q3393998",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770858,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Genital TB</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient presents with secondary amenorrhea for two years and does not bleed when given estrogen and progesterone, indicating that the problem lies in the endometrium. The destruction of the endometrium can occur due to two main conditions: Asherman&#39;s syndrome and genital tuberculosis. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Asherman&#39;s syndrome involves intrauterine adhesions typically following a vigorous dilation and curettage (D&amp;C). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Genital tuberculosis, however, causes chronic endometritis, leading to the destruction of the endometrium and the absence of withdrawal bleeding upon hormone administration. The laparoscopy shows whitish caseating lesions on the surface of the uterus, which are characteristic of genital tuberculosis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Endometriosis</span></strong><span style=\"font-size:12.0pt\">: Endometriosis involves the presence of endometrial tissue outside the uterus, commonly causing pelvic pain and infertility. It does not typically result in secondary amenorrhea or the absence of bleeding on hormone administration, and it does not produce the characteristic whitish lesions seen in the laparoscopy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Fibroids</span></strong><span style=\"font-size:12.0pt\">: Uterine fibroids are benign smooth muscle tumors of the uterus. They can cause menorrhagia, pelvic pressure, and pain but do not lead to secondary amenorrhea or absence of withdrawal bleeding upon hormone administration. Fibroids also do not present with caseating lesions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Sarcoidosis</span></strong><span style=\"font-size:12.0pt\">: Sarcoidosis is a multisystem granulomatous disease that rarely affects the genital tract. It does not cause endometrial destruction, secondary amenorrhea, or the absence of withdrawal bleeding when given hormones, nor does it produce the characteristic uterine lesions seen in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Genital tuberculosis can cause chronic endometritis and endometrial destruction, leading to secondary amenorrhea and absence of withdrawal bleeding on hormone administration, with characteristic whitish caseating lesions visible on laparoscopy.</span></span></p>",
      "correct_choice_id": 227116,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74684,
      "choices": [
        {
          "id": 297649,
          "text": "<p><span style=\"font-size:16px;\">Abdominal pain or discomfort is the commonest presentation for ectopic in 90%</span></p>"
        },
        {
          "id": 297650,
          "text": "<p><span style=\"font-size:16px;\">Oral methotrexate is the choice of medical management in patient with shock</span></p>"
        },
        {
          "id": 297651,
          "text": "<p><span style=\"font-size:16px;\">Ectopic pregnancy is increased in patient with history of PID</span></p>"
        },
        {
          "id": 297652,
          "text": "<p><span style=\"font-size:16px;\">Patient will have reduced levels of progesterone but is not diagnostic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A 26-year woman with six weeks of amenorrhea presents with sharp lower abdominal pain, light vaginal spotting and a bp of 90/ 60 mmHg.&nbsp; pelvic exam reveals right adnexal tenderness. Choose the incorrect statement about this condition. (INICET NOV 2024)</span></p>",
      "unique_key": "Q3341274",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770820,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Oral methotrexate is the choice of medical management in patient with shock</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The clinical scenario describes a classic presentation of <strong>ruptured ectopic pregnancy</strong> with the triad of <strong>amenorrhea, pain, and vaginal bleeding</strong>, along with signs of <strong>shock (BP 90/60 mmHg) and adnexal tenderness.&nbsp;</strong>The statement about oral methotrexate is incorrect because:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>Methotrexate is given as an intramuscular injection, not orally</strong></span></li><li><span style=\"font-size:16px;\">Medical management is contraindicated in patients with shock; they require <strong>immediate surgical intervention</strong></span></li><li><span style=\"font-size:16px;\">Hemodynamic instability is an <strong>absolute contraindication</strong> to medical management</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Abdominal pain or discomfort is the commonest presentation for ectopic in 90%:&nbsp;</strong>Pain is indeed the most common presenting symptom of ectopic pregnancy, occurring in approximately 90% of cases. The clinical triad includes pain, amenorrhea, and vaginal bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Ectopic pregnancy is increased in patient with history of PID:&nbsp;</strong>PID increases the risk of ectopic pregnancy by <strong>causing salpingitis</strong>, which reduces tubal motility and can lead to implantation within the fallopian tube.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Patient will have reduced levels of progesterone but is not diagnostic:&nbsp;</strong>While progesterone levels are typically lower in ectopic pregnancy compared to normal intrauterine pregnancy, this finding is not diagnostic and is not used for clinical decision-making.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Medical management with methotrexate is contraindicated in ectopic pregnancy with hemodynamic instability (shock); such cases require <strong>immediate surgical intervention</strong>.</span></p>",
      "correct_choice_id": 297650,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56999,
      "choices": [
        {
          "id": 227385,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Remove the IUCD gently</span></span></span></p>"
        },
        {
          "id": 227386,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Leave the IUCD in situ</span></span></span></p>"
        },
        {
          "id": 227387,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MTP (Medical Termination of Pregnancy)</span></span></span></p>"
        },
        {
          "id": 227388,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Progesterone support</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 26-year-old conceives on the IUCD. Wants to continue pregnancy. Next best step?</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (NEET PG 2024)</span></span></p>",
      "unique_key": "Q9404177",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771244,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Remove the IUCD gently</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>Ans.</strong> is <strong>Remove the IUCD gently</strong>. When a woman becomes pregnant with an intrauterine contraceptive device (IUCD) in place and wishes to continue the pregnancy, the IUCD should be removed if possible. Leaving the IUCD in situ is associated with risks such as preterm labor, fetal growth restriction, and potential fetal anomalies. While removing the IUCD does carry a slightly increased risk of miscarriage, the overall benefits of removal outweigh the risks of leaving it in place. Removal should be done carefully, with appropriate counseling provided to the patient about the potential risks involved.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Leave the IUCD in situ</span></strong><span style=\"font-size:12.0pt\">: Leaving the IUCD in place is not recommended as it can lead to complications like preterm labor, fetal growth restriction, and other pregnancy complications. Therefore, it should be removed if the patient wishes to continue the pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. MTP (Medical Termination of Pregnancy)</span></strong><span style=\"font-size:12.0pt\">: MTP is not appropriate in this scenario because the patient wishes to continue with the pregnancy. The focus should be on managing the pregnancy safely with the IUCD removed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Progesterone support</span></strong><span style=\"font-size:12.0pt\">: Progesterone support is not indicated in this case as it does not address the main issue, which is the presence of the IUCD and its associated risks if left in place during pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">When a pregnancy occurs with an IUCD in place and the patient wishes to continue, the IUCD should be removed gently to minimize risks associated with leaving it in situ.</span></span></span></p>",
      "correct_choice_id": 227385,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20485,
      "choices": [
        {
          "id": 81902,
          "text": "<p><span style=\"font-size:12pt;\">Prolonged recovery time</span></p>"
        },
        {
          "id": 81903,
          "text": "<p><span style=\"font-size:12pt;\">Not knowing the extent of thermal burns</span></p>"
        },
        {
          "id": 81904,
          "text": "<p><span style=\"font-size:12pt;\">Increased bleeding</span></p>"
        },
        {
          "id": 81905,
          "text": "<p><span style=\"font-size:12pt;\">Increased pain</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman is planned for a laparoscopic hysterectomy. She asks the surgeon for any disadvantages of this procedure. What is the disadvantage of laparoscopic over open surgery? (NEET PG 2023)</span></p>",
      "unique_key": "Q2117708",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771251,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Not knowing the extent of thermal burns</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Laparoscopic hysterectomy is a minimally invasive procedure that offers numerous benefits compared to open surgery. However, one significant disadvantage is the difficulty in assessing the extent of thermal burns. Thermal burns can occur due to the use of electrosurgical instruments, and the limited visual field in laparoscopic surgery can make it challenging to identify and evaluate the full extent of these burns. This limitation is crucial because undetected thermal injury can lead to postoperative complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Prolonged recovery time:</strong> Laparoscopic surgery typically results in a shorter recovery time compared to open surgery. The minimally invasive nature of the procedure means less tissue damage and faster healing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Increased bleeding:</strong> Laparoscopic surgery generally involves less blood loss than open surgery. The precision of the instruments and the smaller incisions contribute to reduced bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Increased pain:</strong> One of the advantages of laparoscopic surgery is less postoperative pain. The smaller incisions and less invasive approach result in decreased pain and discomfort for the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The disadvantage of laparoscopic over open surgery is not knowing the extent of thermal burns.</span></p>",
      "correct_choice_id": 81903,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6118,
      "choices": [
        {
          "id": 24441,
          "text": "<p><span style=\"font-size:12pt;\">Immature teratoma</span></p>"
        },
        {
          "id": 24442,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Mature cystic teratoma</span></p>"
        },
        {
          "id": 24443,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Mucinous cystadenoma</span></p>"
        },
        {
          "id": 24444,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Serous cystadenoma</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A surgically resected specimen of an ovarian mass is shown below. What is the likely diagnosis?&nbsp;</span>(INICET NOV 2022)</p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_xUY8Y7x.jpg\" alt=\"\" width=\"300\" height=\"363\"></span></p>",
      "unique_key": "Q1298522",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770386,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Mature cystic teratoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The specimen shows an ovarian mass with a tuft of hair in a cystic space, which is characteristic of a mature cystic teratoma. Key points about mature cystic teratomas include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Teratomas are germ cell tumors</strong>: They contain various types of tissues derived from the three germ layers: ectoderm, mesoderm, and endoderm.</span></li><li><span style=\"font-size:12pt;\"><strong>Mature cystic teratomas (dermoid cysts)</strong>: Typically unilocular and contain sebaceous material, hair, and sometimes other tissues such as teeth, bone, cartilage, thyroid tissue, and neural tissues.</span></li><li><span style=\"font-size:12pt;\"><strong>Presentation</strong>: Most patients are asymptomatic, but they may present with an abdominal mass, acute pain due to torsion of the ovary, or rarely due to rupture of the cyst.</span></li><li><span style=\"font-size:12pt;\"><strong>Treatment</strong>: Laparoscopic ovarian cystectomy is the treatment of choice for mature teratomas.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Immature teratoma</strong>: These are malignant and contain immature embryonic tissues, often neuroectodermal. They usually occur in younger patients and are more aggressive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Mucinous cystadenoma</strong>: A benign epithelial tumor of the ovary that typically contains mucinous material and does not contain hair or other tissues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Serous cystadenoma</strong>: A benign epithelial tumor of the ovary that typically contains clear serous fluid and lacks the complex tissues found in teratomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Mature cystic teratomas (dermoid cysts) are characterized by the presence of multiple tissue types such as hair, sebaceous material, and sometimes teeth or bone within a cystic ovarian mass.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of gynecology 3<sup>rd</sup> edition pg, Dutta’s textbook of gynecology 6 th edition pg</strong></span></p>",
      "correct_choice_id": 24442,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20490,
      "choices": [
        {
          "id": 81922,
          "text": "<p><span style=\"font-size:12pt;\">Semen analysis for husband</span></p>"
        },
        {
          "id": 81923,
          "text": "<p><span style=\"font-size:12pt;\">Reassure and review the couple after 6 months</span></p>"
        },
        {
          "id": 81924,
          "text": "<p><span style=\"font-size:12pt;\">Hysterolaparoscopy</span></p>"
        },
        {
          "id": 81925,
          "text": "<p><span style=\"font-size:12pt;\">Diagnostic hysteroscopy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 23-year-old woman accompanied by her mother-in-law comes to the infertility clinic. She has been having regular intercourse for 6 months but is not able to conceive. What is the next best step? (NEET PG 2023)</span></p>",
      "unique_key": "Q2422749",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771254,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Reassure and review the couple after 6 months</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Infertility is defined as the inability of a couple to conceive after 1 year of unprotected intercourse. For women under the age of 35, it is recommended to wait and try for one year before starting any investigations. Since the woman in this scenario is only 23 years old and has been trying to conceive for only 6 months, the best approach is to reassure her and advise her to continue trying. Investigations are not indicated at this stage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Semen analysis for husband:</strong> Although semen analysis is an essential part of infertility workup, it is typically not indicated until the couple has been trying to conceive for at least one year if the woman is under 35 years old.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Hysterolaparoscopy:</strong> This is an invasive procedure used to evaluate the female reproductive tract, typically reserved for cases where initial evaluations suggest abnormalities or for women who have been trying to conceive for a longer period.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Diagnostic hysteroscopy:</strong> This procedure is used to examine the inside of the uterus and is generally indicated for investigating suspected uterine abnormalities or after a longer period of unsuccessful conception attempts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For women under 35 years old, it is recommended to try to conceive for one year before starting infertility investigations.</span></p>",
      "correct_choice_id": 81923,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6107,
      "choices": [
        {
          "id": 24397,
          "text": "<p><span style=\"font-size:12pt;\">Reduction in the risk of ovarian cancer</span></p>"
        },
        {
          "id": 24398,
          "text": "<p><span style=\"font-size:12pt;\">Ectopic pregnancy</span></p>"
        },
        {
          "id": 24399,
          "text": "<p><span style=\"font-size:12pt;\">Protection against sexually transmitted diseases including HIV</span></p>"
        },
        {
          "id": 24400,
          "text": "<p><span style=\"font-size:12pt;\">Reduction in the risk of endometrial cancer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The non-contraceptive uses of oral contraceptives include all of the following except?</span>(INICET NOV 2022)</p>",
      "unique_key": "Q9437107",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770383,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Protection against sexually transmitted diseases including HIV</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The non-contraceptive benefits of combined oral contraceptive pills (COCPs) include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Reduction in the risk of ovarian cancer</strong>: COCPs reduce the incidence of ovarian cancer.</span></li><li><span style=\"font-size:12pt;\"><strong>Reduction in the risk of endometrial cancer</strong>: COCPs lower the incidence of endometrial malignancy.</span></li><li><span style=\"font-size:12pt;\"><strong>Reduction in the incidence of ectopic pregnancy</strong>: COCPs decrease the likelihood of ectopic pregnancies by preventing ovulation and thickening cervical mucus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">However, COCPs do not provide protection against sexually transmitted diseases (STDs), including HIV.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Reduction in the risk of ovarian cancer</strong>: COCPs are known to reduce the incidence of ovarian cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Ectopic pregnancy</strong>: COCPs lower the risk of ectopic pregnancy by preventing ovulation and thickening the cervical mucus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Reduction in the risk of endometrial cancer</strong>: COCPs decrease the risk of endometrial cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Combined oral contraceptive pills do not provide protection against sexually transmitted diseases (STDs), including HIV.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of gynecology 3<sup>rd</sup> edition pg 124, Dutta’s textbook of gynecology 6<sup>th</sup> edition pg 489</strong></span></p>",
      "correct_choice_id": 24399,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56961,
      "choices": [
        {
          "id": 227233,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Continue warfarin</span></span></span></p>"
        },
        {
          "id": 227234,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Switch to LMWH</span></span></span></p>"
        },
        {
          "id": 227235,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Immediate caesarean</span></span></span></p>"
        },
        {
          "id": 227236,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;Immediate IOL</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A primigravida presents at 37 weeks. She is a known case of heart disease with a prosthetic valve on warfarin. What is the next best step?&nbsp;</span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2024)</span></span></p>",
      "unique_key": "Q7066339",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771237,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Switch to LMWH</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is a 37-week pregnant woman with a known case of heart disease and a prosthetic valve, currently on warfarin. In pregnant patients with prosthetic heart valves, anticoagulation management is crucial to prevent thromboembolic complications. Warfarin is typically avoided in the late third trimester due to the risk of fetal bleeding and other complications during delivery. It is recommended to switch from warfarin to heparin (usually low molecular weight heparin, LMWH) at around 36 weeks of gestation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Since the patient is still on warfarin at 37 weeks, the immediate action is to switch to LMWH to reduce the risks associated with warfarin during labor and delivery. <strong>Before planning an induction of labor (IOL) or cesarean section, heparin should be stopped 12-24 hours before the planned delivery to minimize the risk of bleeding.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Continue warfarin</span></strong><span style=\"font-size:12.0pt\">: Continuing warfarin at this stage is inappropriate because it increases the risk of bleeding for both the mother and the fetus during labor or delivery. Warfarin crosses the placenta and poses significant risks during the peripartum period.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Immediate cesarean</span></strong><span style=\"font-size:12.0pt\">: There is no immediate indication for a cesarean section based on her anticoagulation status alone. Cesarean delivery would only be indicated for obstetric reasons. Moreover, performing surgery while the patient is on warfarin increases the risk of severe bleeding complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Immediate IOL (Induction of Labor)</span></strong><span style=\"font-size:12.0pt\">: Immediate induction of labor is not the first step as the patient is still on warfarin, which poses a bleeding risk. Before planning any delivery method, it is essential to switch to heparin and allow a safe window without anticoagulation before proceeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In pregnant women with prosthetic heart valves on warfarin, switch to low molecular weight heparin (LMWH) at 36 weeks to reduce the risk of complications during delivery, and stop heparin 12-24 hours before planned delivery.</span></span></span></p>",
      "correct_choice_id": 227234,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44015,
      "choices": [
        {
          "id": 175719,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">OCP</span></span></span></p>"
        },
        {
          "id": 175720,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">OCP + Anti androgen</span></span></span></p>"
        },
        {
          "id": 175721,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Yoga + Exercise</span></span></span></p>"
        },
        {
          "id": 175722,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Counsel for metabolic syndrome</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A young girl presents with menstrual irregularity, acne, increased hair growth with a Ferriman Gallway score of 6, and a BMI of 29. Her mother has diabetes. Which is not a management option?</span><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;&nbsp;</span></span></span>(INICET NOV 2023)</p>",
      "unique_key": "Q2654245",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770450,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) OCP + Anti androgen</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral contraceptive pills (OCPs) are commonly used alone for managing symptoms like acne and menstrual irregularity in PCOS. The addition of anti-androgens is typically reserved for cases where OCPs alone do not manage hirsutism effectively.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. OCP:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> OCPs are a standard treatment for managing menstrual irregularities and hyperandrogenism.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Yoga + Exercise:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Yoga and exercise are recommended for weight management and improving insulin sensitivity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Counsel for metabolic syndrome:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Counseling for metabolic syndrome is crucial given her high BMI and family history of diabetes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In managing PCOS-like symptoms, initial treatment often starts with OCPs. Additional treatments like anti-androgens are considered if initial treatments are insufficient. Lifestyle modifications are always beneficial.</span></span></span></p>",
      "correct_choice_id": 175720,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56835,
      "choices": [
        {
          "id": 226733,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Knee jerk presen</span></span></span></p>"
        },
        {
          "id": 226734,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">RR 18/min</span></span></span></p>"
        },
        {
          "id": 226735,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Visual disturbance</span></span></span></p>"
        },
        {
          "id": 226736,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Urine output 60ml in 4hr</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 23-year-old woman with eclampsia is on a maintenance dose of MgSO₄. When will you stop MgSO₄? (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q2732293",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770856,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Urine output 60ml in 4hr</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Magnesium sulfate (MgSO₄) is used in eclampsia management to prevent seizures. However, MgSO₄ toxicity can occur, which necessitates stopping or adjusting the dose. The first sign of MgSO₄ toxicity is the absence of deep tendon reflexes (DTRs), followed by respiratory depression and reduced urine output. Since magnesium is excreted through the kidneys, urine output is a critical measure of magnesium toxicity risk. A urine output of <strong>less than 30 ml per hour</strong> (or 60 ml in 4 hours) indicates poor excretion and potential toxicity, requiring immediate adjustment or cessation of MgSO₄.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Knee jerk present:</span></strong><span style=\"font-size:12.0pt\"> The presence of a knee jerk (deep tendon reflex) is a positive sign and indicates that magnesium levels are not yet toxic. The absence of DTRs is the first indication of toxicity, so this is not a reason to stop MgSO₄.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. RR 18/min:</span></strong><span style=\"font-size:12.0pt\"> A respiratory rate above 10 breaths per minute is safe when on MgSO₄. Respiratory depression is a sign of advanced toxicity; therefore, a rate of 18 per minute is not concerning.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Visual disturbances:</span></strong><span style=\"font-size:12.0pt\"> Visual disturbances are symptoms associated with eclampsia or pre-eclampsia (e.g., retinal detachment or blurred vision) but are not signs of MgSO₄ toxicity. These do not indicate the need to stop MgSO₄.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MgSO₄ should be stopped if the patient&rsquo;s urine output is less than 30 ml per hour (or 60 ml in 4 hours), as this indicates poor excretion and risk of magnesium toxicity.</span></span></span></p>",
      "correct_choice_id": 226736,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44013,
      "choices": [
        {
          "id": 175711,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Need for blood transfusion</span></span></span></p>"
        },
        {
          "id": 175712,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risk of bladder injury in case of PAS</span></span></span></p>"
        },
        {
          "id": 175713,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risk of bowel injury in case of PAS</span></span></span></p>"
        },
        {
          "id": 175714,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risk of peripartum hysterectomy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 39-year-old G6P2L1A3 presents with a history of previous 2 LSCS with PAS. What will you NOT counsel her about?&nbsp;</span></span></span>(INICET NOV 2023)</p>",
      "unique_key": "Q9611382",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770448,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Risk of bowel injury in case of PAS</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cases of placenta accreta spectrum (PAS), the main risks include bleeding requiring transfusion, bladder injury, and possibly peripartum hysterectomy. Bowel injury is less commonly associated with PAS unless extreme or exceptional surgical complications occur.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Need for blood transfusion:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> It is common to counsel about the need for blood transfusion due to the high risk of hemorrhage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Risk of bladder injury in case of PAS:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bladder injury is a significant risk if the placenta invades the bladder area.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Risk of peripartum hysterectomy:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peripartum hysterectomy may be necessary if the placenta is inseparable from the uterus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When counseling a patient with a history of previous cesarean sections and PAS, focus on the more likely complications such as significant bleeding, bladder injury, and the possibility of needing a hysterectomy, rather than bowel injury.</span></span></span></p>",
      "correct_choice_id": 175713,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56979,
      "choices": [
        {
          "id": 227305,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Grade 3 prolapse with cystocele</span></span></span></p>"
        },
        {
          "id": 227306,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Grade 3 prolapse with rectocele</span></span></span></p>"
        },
        {
          "id": 227307,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Grade 2 prolapse with cystocele</span></span></span></p>"
        },
        {
          "id": 227308,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Grade 2 prolapse with rectocele</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the prolapse?(NEET PG 2024)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-121757.jpg\" style=\"height:386px; width:300px\" /></span></span></p>",
      "unique_key": "Q2984203",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771241,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Grade 3 prolapse with cystocele</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The image shows a Grade 3 prolapse with cystocele, based on the old classification system&nbsp; classification). In this grading system:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Grade 1:</span></strong><span style=\"font-size:12.0pt\"> Prolapse remains inside the vagina.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Grade 2:</span></strong><span style=\"font-size:12.0pt\"> Prolapse reaches the introitus but does not protrude outside.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Grade 3:</span></strong><span style=\"font-size:12.0pt\"> Prolapse extends outside the introitus but not entirely out, and can include anterior vaginal wall prolapse as seen with cystocele.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Grade 4 (Procedentia):</span></strong><span style=\"font-size:12.0pt\"> The entire uterus is outside the introitus.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The observed prolapse primarily shows the anterior vaginal wall protruding, indicating a cystocele. A distinguishing feature between Grade 3 and Grade 4 prolapse is the thumb-finger test: if the thumb and finger can approximate over the swelling completely, it indicates Grade 4 prolapse; otherwise, it is Grade 3.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Grade 3 prolapse with rectocele:</span></strong><span style=\"font-size:12.0pt\"> This option is incorrect because the protrusion is primarily from the anterior wall, characteristic of a cystocele, not a rectocele (posterior wall).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Grade 2 prolapse with cystocele:</span></strong><span style=\"font-size:12.0pt\"> This is incorrect as Grade 2 would not extend outside the introitus, whereas the prolapse seen here is visibly beyond the introitus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Grade 2 prolapse with rectocele:</span></strong><span style=\"font-size:12.0pt\"> This option is incorrect for the same reasons as Grade 2 cystocele; additionally, the prolapse involves the anterior wall rather than the posterior, ruling out rectocele.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Grade 3 prolapse extends outside the introitus and can involve cystocele. Differentiating between Grade 3 and Grade 4 requires the thumb-finger approximation test.</span></span></span></p>",
      "correct_choice_id": 227305,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74686,
      "choices": [
        {
          "id": 297657,
          "text": "<p><span style=\"font-size:16px;\">CPD </span><span style=\"font-size:12.0pt;\">(Cephalopelvic Disproportion)</span></p>"
        },
        {
          "id": 297658,
          "text": "<p><span style=\"font-size:16px;\">Fetal distress</span></p>"
        },
        {
          "id": 297659,
          "text": "<p><span style=\"font-size:16px;\">Maternal exhaustion</span></p>"
        },
        {
          "id": 297660,
          "text": "<p><span style=\"font-size:16px;\">Prolonged 2nd stage labour</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which is not an indication of instrumental vaginal delivery? (INICET NOV 2024)</span></p>",
      "unique_key": "Q9584813",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770822,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) CPD (Cephalopelvic Disproportion)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">CPD is not an indication for instrumental delivery because when there is a <strong>disproportion between the fetal head and maternal pelvis, attempting instrumental delivery would be dangerous and ineffective.</strong> In cases of CPD, cesarean section is the appropriate mode of delivery as attempting to force the baby through an inadequate pelvis could cause trauma to both mother and baby.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Fetal distress:</strong> It is a valid indication for instrumental delivery. When there is fetal distress in the second stage of labor, expedited delivery via forceps or vacuum can help prevent adverse fetal outcomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Maternal exhaustion:</strong> It is a valid indication for instrumental delivery. When the mother is too exhausted to effectively push, instrumental delivery can assist in the birth process.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Prolonged 2nd stage labour:</strong> It is a valid indication for instrumental delivery. When the second stage is prolonged (without CPD), instrumental delivery can help achieve vaginal birth and prevent complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">CPD is an <strong>absolute contraindication</strong> for instrumental vaginal delivery and requires cesarean section, while <strong>fetal distress, maternal exhaustion, and prolonged second stage (without CPD) are valid indications</strong> for instrumental delivery.</span></p>",
      "correct_choice_id": 297657,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56997,
      "choices": [
        {
          "id": 227377,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bacterial vaginosis</span></span></span></p>"
        },
        {
          "id": 227378,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Trichomoniasis</span></span></span></p>"
        },
        {
          "id": 227379,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Candidiasis</span></span></span></p>"
        },
        {
          "id": 227380,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chlamydia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Nugent score is for diagnosis of? (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q9372523",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771243,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A) Bacterial vaginosis</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Nugent score is a microbiological scoring system used for diagnosing bacterial vaginosis (BV). It is based on the examination of a vaginal smear under a microscope to evaluate the presence and quantity of bacterial morphotypes, particularly Lactobacilli, Gardnerella, and Mobiluncus. A high Nugent score indicates a decrease in normal Lactobacilli and an increase in pathogenic bacteria, which is characteristic of bacterial vaginosis. This scoring system provides a more objective and standardized diagnosis compared to clinical criteria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Trichomoniasis: </strong>&nbsp;is incorrect because trichomoniasis is diagnosed through wet mount microscopy, culture, or molecular tests, which detect Trichomonas vaginalis, not by the Nugent score.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">Candidiasis</span></strong><span style=\"font-size:12.0pt\"> <strong>: </strong>is incorrect as it refers to yeast infections typically diagnosed by identifying Candida species on wet mount, KOH preparation, or fungal cultures, not using the Nugent score.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">Chlamydia: </span></strong><span style=\"font-size:12.0pt\">is incorrect since Chlamydia is diagnosed through nucleic acid amplification tests (NAATs), culture, or antigen detection, not by the Nugent scoring system.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>Nugent score</strong> is used for the diagnosis of <strong>bacterial vaginosis</strong>. It is a microbiological scoring system where the vaginal smear is analyzed for the number of lactobacilli and abnormal bacteria. The clinical scoring system for bacterial vaginosis is the <strong>Amsel&#39;s criteria</strong>, which includes the whiff test, clue cells, alkaline pH, and whitish discharge.</span></span></span></p>",
      "correct_choice_id": 227377,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56965,
      "choices": [
        {
          "id": 227249,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Methyl ergometrine</span></span></span></p>"
        },
        {
          "id": 227250,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Carboprost</span></span></span></p>"
        },
        {
          "id": 227251,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Misoprostol</span></span></span></p>"
        },
        {
          "id": 227252,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oxytocin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Drug contraindicated in asthma in PPH (Postpartum Hemorrhage) case?&nbsp;</span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2024)</span></span></p>",
      "unique_key": "Q2602421",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771238,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Carboprost</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Carboprost is a prostaglandin F2 alpha analog that is <strong>commonly used to manage atonic postpartum hemorrhage </strong>by inducing strong uterine contractions. However, it is contraindicated in patients with asthma because it can cause bronchoconstriction and exacerbate asthma symptoms. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Carboprost is also contraindicated in patients with cardiac arrhythmias due to its potent cardiovascular effects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Methyl ergometrine:</span></strong><span style=\"font-size:12.0pt\"> This drug is used for the management of postpartum hemorrhage due to its uterotonic properties, but it does not specifically affect asthma and is not contraindicated in asthmatic patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Misoprostol:</span></strong><span style=\"font-size:12.0pt\"> Misoprostol, a prostaglandin E1 analog, is also used in postpartum hemorrhage for uterine contraction. It does not have the same bronchoconstrictive effects as Carboprost and is not contraindicated in asthma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Oxytocin:</span></strong><span style=\"font-size:12.0pt\"> Oxytocin is a common uterotonic agent used in postpartum hemorrhage management. It has no known bronchoconstrictive properties and is safe for use in asthmatic patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Carboprost (PGF2 alpha) is contraindicated in patients with asthma due to its bronchoconstrictive effects.</span></span></span></p>",
      "correct_choice_id": 227250,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56950,
      "choices": [
        {
          "id": 227189,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;Cervical cancer</span></span></span></p>"
        },
        {
          "id": 227190,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;Pelvic organ prolapse</span></span></span></p>"
        },
        {
          "id": 227191,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;Vulvar cancer</span></span></span></p>"
        },
        {
          "id": 227192,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;Uterine anomalies</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The classification shown is for? (NEET PG 2024)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-121711.jpg\" style=\"height:419px; width:700px\" /></span></span></span></p>",
      "unique_key": "Q9084870",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771233,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp; B) Pelvic organ prolapse</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The classification shown in the image is the <strong>Pelvic Organ Prolapse Quantification (POP-Q) system,</strong> which is used to classify pelvic organ prolapse. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pelvic organ prolapse refers to the descent of pelvic organs, including the uterus, bladder, and rectum, into or outside of the vaginal canal. The POP-Q system is a standardized method that provides detailed measurements of the degree and location of prolapse using specific points and measurements. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">The reference point in this classification is the hymen</span></strong><span style=\"font-size:12.0pt\">, and the system documents anterior wall descent, posterior wall descent, and other prolapse details through a 3x3 grid with <strong>six specific points (Aa, Ba, C, Ap, Bp, and D) and three measurements (genital hiatus, perineal body, and total vaginal length)</strong>. This detailed system allows for accurate assessment and comparison of prolapse severity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Cervical cancer:</strong>&nbsp; is incorrect because cervical cancer staging does not use the POP-Q system. Instead, cervical cancer staging is typically done using FIGO (International Federation of Gynecology and Obstetrics) criteria, which focus on tumor size and spread rather than anatomical descent.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><span style=\"font-size:12.0pt\"><strong>Vulvar cancer: </strong>is incorrect. Vulvar cancer staging is also not related to pelvic organ prolapse or the POP-Q classification. It typically involves examining tumor size and invasion depth.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Uterine anomalies: </strong>is incorrect because uterine anomalies refer to congenital abnormalities of uterine structure and do not involve prolapse quantification. These are usually diagnosed with imaging techniques like ultrasound or MRI, not classified with a system like POP-Q.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The POP-Q system is a specific and standardized classification method used to quantify and describe the extent of pelvic organ prolapse using detailed anatomical measurements. The hymen is the reference point for this classification.</span></span></span></p>",
      "correct_choice_id": 227190,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44009,
      "choices": [
        {
          "id": 175695,
          "text": "<p><span style=\"font-size:12pt;\">E1 + E2</span></p>"
        },
        {
          "id": 175696,
          "text": "<p><span style=\"font-size:12pt;\">E6 + E7</span></p>"
        },
        {
          "id": 175697,
          "text": "<p><span style=\"font-size:12pt;\">L1</span></p>"
        },
        {
          "id": 175698,
          "text": "<p><span style=\"font-size:12pt;\">L2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">What is the antigen present in the recombinant HPV vaccine?&nbsp; </span>(INICET NOV 2023)</p>",
      "unique_key": "Q4742046",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770394,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) L1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The recombinant HPV vaccine primarily includes the L1 protein, which self-assembles into virus-like particles, providing the basis for immune recognition without causing the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. E1 + E2:</strong> E1 and E2 are early viral proteins, not included in vaccines due to their role in viral replication.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. E6 + E7:&nbsp;</strong>E6 and E7 are proteins involved in oncogenesis, not appropriate for vaccine development.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. L2:</strong> L2 is also a capsid protein but not the primary antigen used in current HPV vaccines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The L1 protein of HPV forms the basis of the recombinant HPV vaccine, effectively stimulating an immune response by mimicking the virus structure.</span></p>",
      "correct_choice_id": 175697,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56833,
      "choices": [
        {
          "id": 226725,
          "text": "<p><span style=\"font-size:12.0pt;\">MTP cannot be done as she has crossed 20 weeks</span></p>"
        },
        {
          "id": 226726,
          "text": "<p><span style=\"font-size:12.0pt;\">MTP can be done till 24 weeks</span></p>"
        },
        {
          "id": 226727,
          "text": "<p><span style=\"font-size:12.0pt;\">MTP can be done only if the mother's life is at risk</span></p>"
        },
        {
          "id": 226728,
          "text": "<p><span style=\"font-size:12.0pt;\">MTP can only be done if there is a substantial fetal anomaly</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 14-year-old girl, a victim of rape, presents at 22 weeks for abortion. What advice will you give her? (NEET PG 2024)</span></p>",
      "unique_key": "Q1282968",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770834,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>&nbsp;Ans.&nbsp; B)&nbsp; MTP can be done till 24 weeks</strong></span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">The MTP Act of 2021 in India allows for abortions b/w 20- 24 weeks in specific cases, including:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Rape or sexual assault:</strong> The girl in the question is a victim of rape, which falls under this category.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Risk to maternal life or Disability:</strong> If continuing the pregnancy poses a significant risk to the mother's health or life.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Substantial fetal anomaly:</strong> If the fetus has severe abnormalities incompatible with life or causing significant disability.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Minors:</strong> The girl is 14 years old, making her a minor, and the law provides special considerations for them.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Change in marital status or humanitarian grounds:</strong> These are additional situations where MTP may be considered up to 24 weeks.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. MTP cannot be done as she has crossed 20 weeks:</strong> This is incorrect. While the general limit for MTP is 20 weeks, certain circumstances, like rape, allow for MTP up to 24 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. MTP can be done only if the mother's life is at risk:</strong> This is partially correct. While risk to the mother's life is a valid reason, it's not the only one. Rape is also a valid indication for MTP up to 24 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. MTP can only be done if there is a substantial fetal anomaly:</strong> Again, this is partially correct. Substantial fetal anomaly is one reason, but rape is another valid reason for MTP up to 24 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>In India, under the MTP Act of 2021:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-121328.jpg\" alt=\"\" width=\"800\" height=\"746\"></strong></span></p>",
      "correct_choice_id": 226726,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74687,
      "choices": [
        {
          "id": 297661,
          "text": "<p><span style=\"font-size:16px;\">Candidiasis</span></p>"
        },
        {
          "id": 297662,
          "text": "<p><span style=\"font-size:16px;\">Bacterial vaginosis</span></p>"
        },
        {
          "id": 297663,
          "text": "<p><span style=\"font-size:16px;\">Trichomoniasis</span></p>"
        },
        {
          "id": 297664,
          "text": "<p><span style=\"font-size:16px;\">Neisseria</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A 23-year-old woman presented with malodorous vaginal discharge and whiff test positive. What is the likely cause? (INICET NOV 2024)</span></p>",
      "unique_key": "Q8307999",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770823,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Bacterial vaginosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The important finding in this case is the positive whiff test, which is a <strong>specific diagnostic criterion for bacterial vaginosis (BV).</strong> The whiff test, also known as the <strong>KOH test,</strong> produces a characteristic <strong>fishy or ammonia-like odor when potassium hydroxide is added to the vaginal discharge</strong>. This is one of the Amsel criteria used to diagnose BV.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>BV diagnosis requires three out of four Amsel criteria:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Homogeneous gray-white discharge adhering to vaginal walls</span></li><li><span style=\"font-size:16px;\">Positive whiff test</span></li><li><span style=\"font-size:16px;\">Vaginal pH &gt; 4.5 (alkaline)</span></li><li><span style=\"font-size:16px;\">Presence of clue cells on microscopy (vaginal epithelial cells studded with bacteria)</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Candidiasis:</strong> Incorrect because candidal infections typically present with thick, white, cottage cheese-like discharge and do not have a positive whiff test. The discharge is usually odorless.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Trichomoniasis:</strong> Incorrect because while trichomoniasis can cause malodorous discharge, it typically presents with frothy, greenish-yellow discharge and does not give a positive whiff test.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Neisseria:</strong> Incorrect because Neisseria gonorrhoeae infection typically presents with purulent discharge and does not give a positive whiff test. The discharge is often <strong>yellow-green and may be accompanied by cervical inflammation.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">A positive whiff test is a key diagnostic criterion for bacterial vaginosis as part of the Amsel criteria, where 3 out of 4 criteria must be present for diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_8O8T33Y.png\" width=\"1157\" height=\"564\"></span></p>",
      "correct_choice_id": 297662,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74707,
      "choices": [
        {
          "id": 297741,
          "text": "<p><span style=\"font-size:16px;\">Pachytene</span></p>"
        },
        {
          "id": 297742,
          "text": "<p><span style=\"font-size:16px;\">Prophase</span></p>"
        },
        {
          "id": 297743,
          "text": "<p><span style=\"font-size:16px;\">Leptotene</span></p>"
        },
        {
          "id": 297744,
          "text": "<p><span style=\"font-size:16px;\">Metaphase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The primary oocyte is arrested in: (INICET NOV 2024)</span></p>",
      "unique_key": "Q7282823",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770830,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Prophase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In oogenesis, the primary oocyte is arrested in <strong>prophase of meiosis I. specifically the diplotene stage.&nbsp;</strong>This arrest occurs before birth and continues until puberty. The primary oocytes are formed when primordial germ cells undergo mitosis. These primary oocytes then <strong>enter meiosis I but get arrested in prophase I.</strong> This arrested state continues until puberty, when hormonal changes trigger the resumption of meiosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Pachytene:&nbsp;</strong>This is incorrect. While pachytene is a sub-stage of prophase I, the question asks for the main phase of arrest, which is prophase.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Leptotene:&nbsp;</strong>This is incorrect. Like pachytene, leptotene is also a sub-stage of prophase I, not the main phase where arrest occurs.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D: Metaphase:&nbsp;</strong>The secondary oocyte arrests in metaphase 2.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Primary oocytes are arrested in prophase of meiosis I from fetal life until puberty. This arrest is a crucial event in female reproductive development and understanding of oogenesis.</span></p>",
      "correct_choice_id": 297742,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74685,
      "choices": [
        {
          "id": 297653,
          "text": "<p><span style=\"font-size:16px;\">Corpus luteum&nbsp;</span></p>"
        },
        {
          "id": 297654,
          "text": "<p><span style=\"font-size:16px;\">Primary follicle</span></p>"
        },
        {
          "id": 297655,
          "text": "<p><span style=\"font-size:16px;\">Granulosa cell</span></p>"
        },
        {
          "id": 297656,
          "text": "<p><span style=\"font-size:16px;\">Theca interna</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">An HPE image of the endometrium is shown. The hormone responsible for this is secreted by? (INICET NOV 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ldW7S7Y.png\" width=\"325\" height=\"345\"></span></p>",
      "unique_key": "Q8448712",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770821,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans.</strong> <strong>A) Corpus luteum</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The image shows <strong>secretory phase endometrium</strong>, characterized by tortuous glands rather than straight tubular glands seen in proliferative phase. The secretory changes in the endometrium are caused by <strong>progesterone,</strong> which is primarily secreted by the <strong>corpus luteum</strong> during the post-ovulatory (luteal) phase of the menstrual cycle.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Primary follicle:</strong> This structure produces estrogen, not progesterone, and is present in the proliferative phase of the menstrual cycle. It does not cause secretory changes in the endometrium.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Granulosa cells:</strong> While these cells are important components of follicles and contribute to hormone production, they primarily produce estrogen as part of the developing follicle, not the progesterone responsible for secretory changes.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Theca interna:</strong> These cells work with granulosa cells to produce estrogen during the follicular phase. They are not responsible for progesterone production that causes secretory endometrial changes.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Secretory changes in the endometrium are caused by progesterone, which is primarily secreted by the corpus luteum during the luteal phase of the menstrual cycle.</span></p>",
      "correct_choice_id": 297653,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6129,
      "choices": [
        {
          "id": 24485,
          "text": "<p><span style=\"font-size:12pt;\">LSCS</span></p>"
        },
        {
          "id": 24486,
          "text": "<p><span style=\"font-size:12pt;\">Pfannenstiel incision</span></p>"
        },
        {
          "id": 24487,
          "text": "<p><span style=\"font-size:12pt;\">Upper segment cesarean section</span></p>"
        },
        {
          "id": 24488,
          "text": "<p><span style=\"font-size:12pt;\">Done in OT</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is true regarding perimortem cesarean section?&nbsp;</span>(INICET NOV 2022)</p>",
      "unique_key": "Q1663441",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770390,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Upper segment cesarean section</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">An upper segment cesarean section is performed during a perimortem cesarean section (PMCS). PMCS is an emergency cesarean delivery of a woman who is expected to die within the next few moments or has just died.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Key points about PMCS:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Timing</strong>: According to the AHA 2020 Guidelines for CPR, perimortem cesarean should be considered if there is no return of spontaneous circulation within 5 minutes in a pregnant woman who has experienced total cardiopulmonary arrest.</span></li><li><span style=\"font-size:12pt;\"><strong>Purpose</strong>: The goal of PMCS is to improve maternal and fetal outcomes by relieving the compression of the inferior vena cava (IVC) by the gravid uterus, which enhances venous return and diaphragmatic displacement. This, in turn, improves respiratory dynamics and resuscitative efforts.</span></li><li><span style=\"font-size:12pt;\"><strong>Fetal Outcome</strong>: The infant has a higher chance of survival if PMCS is performed within 10 minutes of maternal death.</span></li><li><span style=\"font-size:12pt;\"><strong>Surgical Technique</strong>: A classical upper-segment cesarean section with a vertical uterine incision is performed.</span></li><li><span style=\"font-size:12pt;\"><strong>Location</strong>: PMCS does not need to be done in the operating theatre (OT); it can be done wherever the patient is located to expedite the process.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. LSCS</strong>: Lower segment cesarean section (LSCS) is not typically used in PMCS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Pfannenstiel incision</strong>: This is a horizontal incision typically used in elective cesarean sections, not in emergency PMCS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Done in OT</strong>: PMCS does not need to be performed in the operating theatre; it can be done immediately at the site of the patient to save time.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Perimortem cesarean section (PMCS) involves performing a classical upper-segment cesarean section with a vertical uterine incision in an emergency situation to improve maternal and fetal outcomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: </strong></span><a href=\"https://www.ncbi.nlm.nih.gov/books/NBK459265/\"><span style=\"font-size:12pt;\"><strong><u>https://www.ncbi.nlm.nih.gov/books/NBK459265/</u></strong></span></a></p>",
      "correct_choice_id": 24487,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74681,
      "choices": [
        {
          "id": 297637,
          "text": "<p><span style=\"font-size:16px;\">Imperforate Hymen</span></p>"
        },
        {
          "id": 297638,
          "text": "<p><span style=\"font-size:16px;\">Transverse vaginal septum</span></p>"
        },
        {
          "id": 297639,
          "text": "<p><span style=\"font-size:16px;\">Mayer-Rokitansky-Küster-Hauser syndrome</span></p>"
        },
        {
          "id": 297640,
          "text": "<p><span style=\"font-size:16px;\">OHVIRA syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 14-year-old girl with primary amenorrhea presents to the outpatient department with complaints of an inability to pass urine and cyclical abdominal pain. On examination, a bluish hue is observed in the vagina. What is the most likely cause of her condition? (INICET NOV 2024)</span></p>",
      "unique_key": "Q9172030",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770717,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Imperforate Hymen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The features in this case pointing to <strong>imperforate hymen</strong> are:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Primary amenorrhea with <strong>cyclical pain (cryptomenorrhea)</strong></span></li><li><span style=\"font-size:16px;\">Urinary retention</span></li><li><span style=\"font-size:16px;\">Bluish hue/bulge in vagina</span></li><li><span style=\"font-size:16px;\">Adolescent age group</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">The bluish hue is <strong>pathognomonic of imperforate hymen</strong> as the collected menstrual blood (hematocolpos) is visible through the thin hymenal membrane.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong> <strong>B. Transverse vaginal septum:</strong> While it can present similarly like imperforate hymen, a transverse vaginal septum is <strong>thicker</strong> and would not show the characteristic <strong>bluish hue</strong>. An <strong>MRI&nbsp;</strong>would be needed for diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong> <strong>C. Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome:</strong> This condition involves absence of uterus. There would be no menstrual blood collection and thus no cyclical pain or bluish hue, as there is no uterus to generate menstrual flow.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong> <strong>D. OHVIRA syndrome:</strong> This presents with <strong>normal menstruation</strong> as there is only partial obstruction of vagina <strong>(hemivagina)</strong> and uterine didelphys. Patients typically have gradually <strong>worsening dysmenorrhea</strong> and may develop <strong>endometriosis</strong>. It is associated with <strong>ipsilateral renal agenesis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Imperforate hymen presents with primary amenorrhea, cyclical abdominal pain, and urinary retention in adolescent girls. The pathognomonic finding is a bluish bulge in the vagina due to collected menstrual blood (hematocolpos).</span></p>",
      "correct_choice_id": 297637,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44016,
      "choices": [
        {
          "id": 175723,
          "text": "<p><span style=\"font-size:12pt;\">Do UPT and then give DMPA</span></p>"
        },
        {
          "id": 175724,
          "text": "<p><span style=\"font-size:12pt;\">DMPA + 7 days backup</span></p>"
        },
        {
          "id": 175725,
          "text": "<p><span style=\"font-size:12pt;\">DMPA from next cycle</span></p>"
        },
        {
          "id": 175726,
          "text": "<p><span style=\"font-size:12pt;\">Give DMPA, no backup required</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female patient taking DMPA came 14 days late. What should be advised to her?&nbsp;</span>(INICET NOV 2023)</p>",
      "unique_key": "Q7562248",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770451,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Give DMPA, no backup required</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">When a patient is up to 15 days late for a Depo-Provera (DMPA) injection, it is generally safe to administer the injection without additional contraceptive backup.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Do UPT and then give DMPA:</strong> Pregnancy testing is typically not required unless the delay exceeds 15 days.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. DMPA + 7 days backup:</strong> Backup contraception is recommended if the delay exceeds 15 days.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. DMPA from next cycle:</strong> There is no need to wait until the next cycle if the delay is within 15 days.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For patients receiving DMPA who are less than 15 days late for their injection, it can be administered without the need for additional contraceptive measures or delay.</span></p>",
      "correct_choice_id": 175726,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Controversial",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20492,
      "choices": [
        {
          "id": 81930,
          "text": "<p><span style=\"font-size:12pt;\">Herpes simplex</span></p>"
        },
        {
          "id": 81931,
          "text": "<p><span style=\"font-size:12pt;\">Genital tuberculosis</span></p>"
        },
        {
          "id": 81932,
          "text": "<p><span style=\"font-size:12pt;\">Vaginal candidiasis</span></p>"
        },
        {
          "id": 81933,
          "text": "<p><span style=\"font-size:12pt;\">Neisseria gonorrhoea</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old woman with a history of multiple sexual partners presents with lower abdominal pain for 1 month. She experiences minimal discharge and complaints of intermenstrual bleeding. What is the most likely cause? (NEET PG 2023)</span></p>",
      "unique_key": "Q9847050",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771255,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Neisseria gonorrhoea</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The history of multiple sexual partners and lower abdominal pain with discharge and intermenstrual bleed suggests a diagnosis of Pelvic Inflammatory Disease, of which cause can be N. Gonorrhoea among the given options.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Pelvic Inflammatory Disease</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/whatsapp-image-2023-06-12-at-1901210149.jpg\" alt=\"\" width=\"1000\" height=\"1180\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Treatment –</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">KIT 6 (Yellow) – Tab Cefixime 400mg 1 Tab</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Tab Metronidazole 400 mg (1 tab BD x 1 days)</span></li><li><span style=\"font-size:12pt;\">&nbsp;Tab Doxycycline 100 mg (1 tab BD x 21 days)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Herpes simplex</strong>: Herpes simplex causes painful genital ulcers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Genital tuberculosis</strong>: Genital tuberculosis is seen in sexually inactive females</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Vaginal candidiasis</strong>: Vaginal candidiasis presents as intense pruritus and white discharge.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Pelvic Inflammatory Disease (PID) is most commonly caused by sexually transmitted infections, with Neisseria gonorrhoeae being a major pathogen, especially in women with multiple sexual partners presenting with lower abdominal pain and intermenstrual bleeding.</span></p>",
      "correct_choice_id": 81933,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6121,
      "choices": [
        {
          "id": 24453,
          "text": "<p><span style=\"font-size:12pt;\">Warning bleeds</span></p>"
        },
        {
          "id": 24454,
          "text": "<p><span style=\"font-size:12pt;\">Dark painful bleeding</span></p>"
        },
        {
          "id": 24455,
          "text": "<p><span style=\"font-size:12pt;\">Uterine tenderness</span></p>"
        },
        {
          "id": 24456,
          "text": "<p><span style=\"font-size:12pt;\">Increased large uterine size</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is seen in placenta previa?&nbsp;</span>(INICET NOV 2022)</p>",
      "unique_key": "Q1588915",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770387,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Warning bleeds</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Placenta previa is a condition where the placenta is implanted in the lower uterine segment, either over or close to the internal cervical os. Key features of placenta previa include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Warning bleeds</strong>: Also known as sentinel bleeds, are sudden-onset, recurrent, painless vaginal bleeding episodes that typically begin in the third trimester or during labor.</span></li><li><span style=\"font-size:12pt;\"><strong>Soft, non-tender uterus</strong>: The abdominal examination reveals a soft and non-tender uterus, with the fundal height proportionate to the gestational age.</span></li><li><span style=\"font-size:12pt;\"><strong>Normal fetal heart rate</strong>: The fetal heart rate is usually normal unless there is severe bleeding due to a large separation.</span></li><li><span style=\"font-size:12pt;\"><strong>Malpresentations are common</strong>: Due to the lower placement of the placenta.</span></li><li><span style=\"font-size:12pt;\"><strong>Diagnosis</strong>: Confirmed via transabdominal sonography or transvaginal sonography, which is safe and more accurate.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Dark painful bleeding</strong>: This is characteristic of placental abruption, not placenta previa. Placental abruption presents with painful, dark vaginal bleeding due to the premature separation of the placenta.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Uterine tenderness</strong>: Uterine tenderness is also a feature of placental abruption, where the uterus becomes firm and tender due to bleeding and clot formation behind the placenta.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Increased large uterine size</strong>: This is not a specific feature of placenta previa. Uterine size in placenta previa is proportionate to the gestational age.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Placenta previa typically presents with painless, recurrent vaginal bleeding (warning bleeds) in the third trimester or during labor, with a soft, non-tender uterus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 26<sup>th</sup> edition pg1940, Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg 307</strong></span></p>",
      "correct_choice_id": 24453,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20482,
      "choices": [
        {
          "id": 81890,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">10 to 12 weeks</span></span></span></p>"
        },
        {
          "id": 81891,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">8 to 10 weeks</span></span></span></p>"
        },
        {
          "id": 81892,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After 14 weeks</span></span></span></p>"
        },
        {
          "id": 81893,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After 20 weeks</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A primigravida presents to you in her early pregnancy with anemia. She is 7 weeks pregnant as seen on ultrasound. Her haemoglobin level is 9 g/dL. When should the iron supplements be started for her?</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"> (NEET PG 2023)</span></span></span></p>",
      "unique_key": "Q5238038",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771249,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 8 to 10 weeks</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prophylaxis for anemia in pregnancy is generally started at 14 weeks and continued for 180 days. However, the given question indicates that the patient has moderate anemia and requires immediate treatment. Among the provided options, the earliest time to start iron supplements is 8 to 10 weeks, making this the correct answer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">According to the Anemia Mukt Bharat campaign, the severity of anemia is classified as follows:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mild: 10-10.9 g%</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Moderate: 7-9 g%</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Severe: &lt;7 g%</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Testing and Treating Mild and Moderate Anemia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mild anemia or moderate anemia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Give 2 tablets of iron.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Late presentation in pregnancy or inability to tolerate oral iron:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Administer parenteral iron, such as iron carboxymaltose (FeCM).</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treating Severe Anemia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemoglobin &lt; 7 g%:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Administer iron carboxymaltose.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Late presentation in the third trimester with severe anemia or hemoglobin &lt; 5 g%:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Admit the patient for further management.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 10 to 12 weeks</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While this is an earlier time frame than the standard prophylactic start, it is not as early as 8 to 10 weeks, which is necessary for moderate anemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. After 14 weeks:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is the standard time for starting prophylactic iron supplements but is too late for a patient with moderate anemia who requires immediate treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. After 20 weeks:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is much too late for initiating treatment for anemia, especially for a patient with moderate anemia needing earlier intervention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cases of moderate anemia (Hb 7-9 g/dL) in early pregnancy, iron supplements should be started as early as 8 to 10 weeks to ensure timely treatment.</span></span></span></p>",
      "correct_choice_id": 81891,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74682,
      "choices": [
        {
          "id": 297641,
          "text": "<p><span style=\"font-size:16px;\">Primary ovarian insufficiency</span></p>"
        },
        {
          "id": 297642,
          "text": "<p><span style=\"font-size:16px;\">Hypogonadotropic hypogonadism</span></p>"
        },
        {
          "id": 297643,
          "text": "<p><span style=\"font-size:16px;\">Hypergonadotropic hypogonadism</span></p>"
        },
        {
          "id": 297644,
          "text": "<p><span style=\"font-size:16px;\">Normogonadotropic normogonadism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 24-year-old athlete woman presents the gyne clinic with complaints of secondary amenorrhea and primary infertility. She has a history of low body weight and occasional dieting to maintain her physique with a current BMI of 17.5. Laboratory investigations reveal the following hormone levels LH=0.3, FSH=2, Prolactin=20ng, TSH: 1.2, BMI: 17.5. She likely to suffer from? (INICET NOV 2024)</span></p>",
      "unique_key": "Q3425379",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770718,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Hypogonadotropic hypogonadism</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The features in this case point to <strong>hypogonadotropic hypogonadism</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Low FSH and LH levels (FSH=2, LH=0.3) - normal values are usually between 2-10</span></li><li><span style=\"font-size:16px;\">Athletic female with low BMI (17.5)</span></li><li><span style=\"font-size:16px;\">History of dieting and low body weight This condition is typically seen in athletes and women with low BMI, where reduced body fat leads to decreased production of gonadotropins (LH and FSH) by the pituitary gland.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Primary ovarian insufficiency:</strong> Incorrect because this condition presents with high FSH and LH values due to lack of negative feedback from the ovaries.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Hypergonadotropic hypogonadism: </strong>Incorrect because this presents with high, not low, gonadotropin levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Normogonadotropic normogonadism:&nbsp;</strong>Incorrect because the patient has low, not normal, gonadotropin levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Hypogonadotropic hypogonadism in female athletes is characterized by:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Low FSH and LH levels (&lt;2)</span></li><li><span style=\"font-size:16px;\">Associated with low BMI and excessive exercise</span></li><li><span style=\"font-size:16px;\">Common cause of secondary amenorrhea in athletes</span></li></ul>",
      "correct_choice_id": 297642,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56942,
      "choices": [
        {
          "id": 227157,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Both caesarean</span></span></span></p>"
        },
        {
          "id": 227158,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Both vaginal</span></span></span></p>"
        },
        {
          "id": 227159,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Image 1: Vaginal; image 2: Cesarean</span></span></span></p>"
        },
        {
          "id": 227160,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Image 1: Cesarean; image 2: Vaginal</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What would be the mode of delivery in images 1 and 2? (NEET PG 2024)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-121428.jpg\" style=\"height:252px; width:400px\" /></span></span></p>",
      "unique_key": "Q1989168",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770861,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Image 1: Vaginal; image 2: Cesarean</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In the provided images, the presentation of the twins is crucial in determining the mode of delivery:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Image 1:</span></strong><span style=\"font-size:12.0pt\"> Both twins are in a cephalic presentation (head down), making it safe to consider vaginal delivery. Twin pregnancies where both twins present cephalically are usually managed vaginally unless there are other contraindications.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Image 2:</span></strong><span style=\"font-size:12.0pt\"> The first twin (Twin A or the lowermost baby) is in a breech presentation, while the second twin is cephalic. In this scenario, a cesarean section is preferred to avoid complications associated with breech delivery, such as cord prolapse or head entrapment. Therefore, cesarean delivery is the recommended mode for this presentation.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Indications for cesarean in twin pregnancy:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">First twin is non-cephalic</span></strong><span style=\"font-size:12.0pt\"> (breech or transverse presentation).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Monochorionic, monoamniotic twins</span></strong><span style=\"font-size:12.0pt\">: Elective LSCS at around 34 weeks.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Conjoined twins</span></strong><span style=\"font-size:12.0pt\">.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Higher-order multiples</span></strong><span style=\"font-size:12.0pt\"> (triplets, quadruplets, or more).</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In twin pregnancies, the mode of delivery is determined primarily by the presentation of the first twin. If the first twin is cephalic, vaginal delivery can be considered, but if the first twin is non-cephalic (e.g., breech), a cesarean section is generally recommended.</span></span></span></p>",
      "correct_choice_id": 227159,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20479,
      "choices": [
        {
          "id": 81878,
          "text": "<p><span style=\"font-size:12pt;\">Abruptio placenta</span></p>"
        },
        {
          "id": 81879,
          "text": "<p><span style=\"font-size:12pt;\">Hydrocephalus of fetus</span></p>"
        },
        {
          "id": 81880,
          "text": "<p><span style=\"font-size:12pt;\">Polyhydramnios</span></p>"
        },
        {
          "id": 81881,
          "text": "<p><span style=\"font-size:12pt;\">Fetal-maternal ascites</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman presents to OPD at 36 weeks of gestation and presents with complaints of breathlessness and excessive abdominal distension. On examination, fetal movements are normal, fetal parts not easily felt and muffled fetal heartbeat is heard. Symphysis fundal height came out to be 41 cm. Per abdomen examination reveals tense abdomen but not tender. What can be the most likely diagnosis?&nbsp;</span>(NEET PG 2023)</p>",
      "unique_key": "Q7924639",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771247,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Polyhydramnios</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The given scenario of 36 weeks pregnant woman with breathlessness and excessive abdominal distension and fundal height 41 cm, points to a diagnosis of polyhydramnios.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Polyhydramnios</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/whatsapp-image-2023-06-12-at-1901210143.jpg\" alt=\"\" width=\"1000\" height=\"1300\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Abruptio placenta</strong>: Abruption Placenta presents with abdominal pain, vaginal bleeding, and uterine tenderness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Hydrocephalus of fetus</strong>: Hydrocephalus of the fetus leads to increased head circumference in the fetus, which may cause an increased symphysis fundal height but unlikely to cause breathlessness and abdominal distension to this extent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Fetal-maternal ascites</strong>: Patients of Fetal-maternal ascites commonly present with edema, proteinuria, hypertension, elevated liver enzymes and headache.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In a 36 weeks pregnant woman with breathlessness and excessive abdominal distension and fundal height 41 cm, it most likely points to a diagnosis of polyhydramnios.</span></p>",
      "correct_choice_id": 81880,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56935,
      "choices": [
        {
          "id": 227129,
          "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;45 XO</span></p>"
        },
        {
          "id": 227130,
          "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;46 XX</span></p>"
        },
        {
          "id": 227131,
          "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;47 XXY</span></p>"
        },
        {
          "id": 227132,
          "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;46 XY</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Scenario with primary amenorrhea with secondary sexual characters present, uterus and ovaries present with an image as shown. What is the likely karyotype<strong>?</strong> (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-121400.jpg\" alt=\"\" width=\"300\" height=\"293\"></span></p>",
      "unique_key": "Q4220180",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770859,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 46 XX</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The scenario describes a patient with primary amenorrhea, secondary sexual characteristics, and a presence of the uterus and ovaries. The image shows an obstruction in the vaginal opening, which is likely an imperforate hymen. The presence of secondary sexual characteristics and normal internal reproductive organs, such as the uterus and ovaries, indicates that the chromosomal pattern is normal female, 46 XX. The karyotype is not affected by the physical obstruction causing the amenorrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 45 XO:</strong> This karyotype is characteristic of Turner syndrome, where patients usually have streak ovaries, lack secondary sexual characteristics, and have other distinct features like webbed neck and short stature, none of which are present in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 47 XXY:</strong> This karyotype corresponds to Klinefelter syndrome, typically found in males who present with hypogonadism, tall stature, and often gynecomastia. It is not applicable to the described scenario with a female presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 46 XY:</strong> This karyotype is associated with male individuals or conditions like Androgen Insensitivity Syndrome. The presence of normal female internal reproductive structures (uterus and ovaries) rules out 46 XY.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Primary amenorrhea with normal development of secondary sexual characteristics and intact internal female reproductive organs (uterus and ovaries) generally indicates a normal female karyotype, 46 XX.</span></p>",
      "correct_choice_id": 227130,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44014,
      "choices": [
        {
          "id": 175715,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rubella</span></span></span></p>"
        },
        {
          "id": 175716,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytomegalovirus (CMV)</span></span></span></p>"
        },
        {
          "id": 175717,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HSV 2</span></span></span></p>"
        },
        {
          "id": 175718,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chicken pox</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which infection contracted in pregnancy won&#39;t be teratogenic?</span></span>(INICET NOV 2023)</p>",
      "unique_key": "Q6538490",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770449,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) HSV 2</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Herpes Simplex Virus type 2 (HSV 2) primarily causes genital infections and is not generally teratogenic. It poses risks primarily at delivery if there is an active infection, leading to neonatal herpes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Rubella:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Rubella is highly teratogenic, especially if contracted in the first trimester.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Cytomegalovirus (CMV):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytomegalovirus (CMV) is a common cause of congenital infections and can result in severe fetal abnormalities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Chicken pox:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Chickenpox (Varicella) can lead to congenital varicella syndrome, which is teratogenic.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among the listed infections, HSV 2 is not considered teratogenic, although it requires careful management to prevent neonatal transmission during delivery.</span></span></span></p>",
      "correct_choice_id": 175717,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44017,
      "choices": [
        {
          "id": 175727,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral contraceptive pills (OCPs)</span></span></span></p>"
        },
        {
          "id": 175728,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Functional ovarian cyst</span></span></span></p>"
        },
        {
          "id": 175729,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparity</span></span></span></p>"
        },
        {
          "id": 175730,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polycystic ovary syndrome (PCOS)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is a risk factor for progression to borderline ovarian tumor?</span></span>&nbsp;(INICET NOV 2023)</p>",
      "unique_key": "Q4629286",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770502,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Nulliparity</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparity is associated with a slightly increased risk of ovarian tumors, including borderline ovarian tumors, possibly due to uninterrupted ovulation and hormonal fluctuations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Oral contraceptive pills (OCPs:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Oral contraceptive pills (OCPs) are known to reduce the risk of ovarian cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Functional ovarian cyst:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Functional ovarian cysts typically do not progress to ovarian tumors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Polycystic ovary syndrome (PCOS):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Polycystic ovary syndrome (PCOS) has not been strongly linked with increased risk of borderline ovarian tumors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparity is recognized as a risk factor for borderline ovarian tumors, highlighting the influence of reproductive factors on ovarian health.</span></span></span></p>",
      "correct_choice_id": 175729,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74695,
      "choices": [
        {
          "id": 297693,
          "text": "<p><span style=\"font-size:16px;\">Dimeric Inhibin B</span></p>"
        },
        {
          "id": 297694,
          "text": "<p><span style=\"font-size:16px;\">Beta hCG</span></p>"
        },
        {
          "id": 297695,
          "text": "<p><span style=\"font-size:16px;\">AFP</span></p>"
        },
        {
          "id": 297696,
          "text": "<p><span style=\"font-size:16px;\">Unconjugated Estriol&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A 16 weeks pregnant woman planned for Anomaly scan. Following the scan, the patient was advised to take a Quadruple test. Which is not part of the Quadruple test? (INICET NOV 2024)</span></p>",
      "unique_key": "Q6093402",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770825,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Dimeric Inhibin B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The quadruple test is a second-trimester screening test performed between 15-20 weeks of pregnancy. The correct components of the quadruple test are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>Alpha-fetoprotein (AFP)</strong></span></li><li><span style=\"font-size:16px;\"><strong>Beta hCG</strong></span></li><li><span style=\"font-size:16px;\"><strong>Inhibin A (not B)</strong></span></li><li><span style=\"font-size:16px;\"><strong>Unconjugated estriol</strong></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\">In pregnancies with Down syndrome:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Beta hCG and Inhibin A levels are elevated</span></li><li><span style=\"font-size:16px;\">AFP and unconjugated estriol levels are decreased</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The quadruple test consists of four specific markers: <strong>AFP, beta hCG, Inhibin A (not B), and unconjugated estriol.</strong> Dimeric Inhibin B is not a component of this test.</span></p>",
      "correct_choice_id": 297693,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6125,
      "choices": [
        {
          "id": 24469,
          "text": "<p><span style=\"font-size:12pt;\">Conservative management</span></p>"
        },
        {
          "id": 24470,
          "text": "<p><span style=\"font-size:12pt;\">Administer tocolytics and deliver at 37 wks</span></p>"
        },
        {
          "id": 24471,
          "text": "<p><span style=\"font-size:12pt;\">Give steroid cover and wait until steroid cover is complete.</span></p>"
        },
        {
          "id": 24472,
          "text": "<p><span style=\"font-size:12pt;\">Treat hypertension, administer MgSO4, and consider termination of pregnancy.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman with 35 weeks+5 days gestation complains of epigastric pain, headache, and blurring of vision. Her blood pressure is 170/110 mmHg. She is in labor pain. Examination of the cervix shows a 3 cm dilatation with a bag of liquor. What is the appropriate management?&nbsp;</span>(INICET NOV 2022)</p>",
      "unique_key": "Q7974292",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770388,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Treat hypertension, administer MgSO4, and consider termination of pregnancy.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">This pregnant woman is presenting with symptoms and signs of severe pre-eclampsia, which include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Epigastric pain</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Headache</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Blurring of vision</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Severe hypertension</strong>: Blood pressure of 170/110 mmHg.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In the context of severe pre-eclampsia at 35 weeks+5 days gestation, the management should include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Treating hypertension</strong>: Immediate blood pressure control is crucial to prevent complications such as eclampsia, stroke, or placental abruption.</span></li><li><span style=\"font-size:12pt;\"><strong>Administering magnesium sulfate (MgSO4)</strong>: This is done to prevent eclamptic seizures.</span></li><li><span style=\"font-size:12pt;\"><strong>Consideration for termination of pregnancy</strong>: In cases of severe pre-eclampsia at or beyond 34 weeks, the recommended course of action is to expedite delivery to prevent further maternal and fetal complications.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Conservative management</strong>: Conservative management is not appropriate for severe pre-eclampsia due to the high risk of complications for both the mother and the fetus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Administer tocolytics and deliver at 37 weeks</strong>: Tocolytics are contraindicated in severe pre-eclampsia as the goal is to deliver the baby as soon as the condition is stable, rather than delaying delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Give steroid cover and wait until steroid cover is complete</strong>: As the patient is already beyond 34 weeks of gestation, steroid administration for fetal lung maturity is not necessary, and immediate delivery is preferred.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In cases of severe pre-eclampsia at or beyond 34 weeks of gestation, immediate management involves controlling hypertension, administering magnesium sulfate to prevent seizures, and expediting delivery.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/02/untitled-291.jpg\" alt=\"\" width=\"500\" height=\"593\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Williams textbook of obstetrics 26<sup>th</sup> edition pg 1850, &nbsp;Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg267</strong></span></p>",
      "correct_choice_id": 24472,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6110,
      "choices": [
        {
          "id": 24409,
          "text": "<p><span style=\"font-size:12pt;\">Turner syndrome</span></p>"
        },
        {
          "id": 24410,
          "text": "<p><span style=\"font-size:12pt;\">Kallmann syndrome</span></p>"
        },
        {
          "id": 24411,
          "text": "<p><span style=\"font-size:12pt;\">Androgen insensitivity syndrome</span></p>"
        },
        {
          "id": 24412,
          "text": "<p><span style=\"font-size:12pt;\">Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old presents with absent menses. Examination shows widely spaced nipples, webbed neck, and Tanner grade 1 breast development. USG shows streak ovaries. Investigation shows raised FSH, raised LH, and reduced estradiol. What is the diagnosis?&nbsp;</span>(INICET NOV 2022)</p>",
      "unique_key": "Q6425081",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770384,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Turner syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The patient's clinical features are strongly suggestive of Turner syndrome (45XO), a condition characterized by:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Widely spaced nipples</strong>: Shield chest appearance.</span></li><li><span style=\"font-size:12pt;\"><strong>Webbed neck</strong>: Due to congenital lymphedema.</span></li><li><span style=\"font-size:12pt;\"><strong>Tanner grade 1 breast development</strong>: Indicates no breast development.</span></li><li><span style=\"font-size:12pt;\"><strong>Streak ovaries</strong> on ultrasound: Ovaries that are underdeveloped and nonfunctional.</span></li><li><span style=\"font-size:12pt;\"><strong>Hormonal profile</strong>: Raised FSH and LH due to lack of negative feedback from the ovaries, and reduced estradiol indicating ovarian failure.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Other clinical features of Turner syndrome include short stature, primary amenorrhea, congenital heart defects, and renal anomalies. The syndrome results in hypergonadotropic hypogonadism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Kallmann syndrome</strong>: It is characterized by hypogonadotropic hypogonadism and anosmia (lack of sense of smell), not hypergonadotropic hypogonadism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Androgen insensitivity syndrome</strong>: 46XY karyotype with female external genitalia, well-developed breasts, absent axillary and pubic hair, and gonads are testes, not streak ovaries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Mayer-Rokitansky-Küster-Hauser syndrome</strong>: Mullerian agenesis, where secondary sexual characters are present but the uterus, fallopian tubes, and upper vagina are absent. This syndrome does not present with webbed neck or widely spaced nipples.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Turner syndrome is characterized by primary amenorrhea, streak ovaries, hypergonadotropic hypogonadism, widely spaced nipples, and a webbed neck.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of Gynecology 3<sup>rd</sup> edition pg411, Dutta’s textbook of gynecology 6<sup>th</sup> edition pg 441</strong></span></p>",
      "correct_choice_id": 24409,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56830,
      "choices": [
        {
          "id": 226713,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2B</span></span></span></p>"
        },
        {
          "id": 226714,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">3A</span></span></span></p>"
        },
        {
          "id": 226715,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">3B</span></span></span></p>"
        },
        {
          "id": 226716,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">3C</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presented to the OPD as a known case of cervical cancer. On further evaluation, the pelvic side wall was found to be involved, and hydronephrosis was also seen. Identify the stage of cervical cancer. (NEET PG 2024)</span></span></p>",
      "unique_key": "Q1193352",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770831,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) 3B</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stage 3B cervical cancer is characterized by the involvement of the pelvic side wall and the presence of hydronephrosis or non-functioning kidney due to ureteric obstruction. In this stage, the cancer has extended to the lateral pelvic wall, and often the tumor affects the ureter, leading to obstructive uropathy. This progression indicates a significant local spread of the disease, distinguishing it from earlier stages where cancer is confined closer to the cervix or upper parts of the vagina.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. 2B:</span></strong><span style=\"font-size:12.0pt\"> Stage 2B cervical cancer involves the spread of cancer into the parametrium but does not reach the lateral pelvic wall. It does not involve hydronephrosis or ureteric obstruction, which are key features distinguishing Stage 3B.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. 3A:</span></strong><span style=\"font-size:12.0pt\"> Stage 3A involves the spread of cancer to the lower third of the vagina without extension to the pelvic wall or causing hydronephrosis. It does not involve the pelvic side wall or ureteric complications, unlike Stage 3B.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. 3C:</span></strong><span style=\"font-size:12.0pt\"> Stage 3C is characterized by the spread of cancer to pelvic or para-aortic lymph nodes but does not necessarily involve the pelvic side wall or hydronephrosis. Stage 3C is further divided into 3C1 (pelvic lymph nodes) and 3C2 (para-aortic lymph nodes), differing from the pelvic side wall involvement seen in Stage 3B.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Stages of cervical cancer:&nbsp; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-121230.jpg\" style=\"height:750px; width:887px\" /></span></strong></span></span></p>",
      "correct_choice_id": 226715,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56939,
      "choices": [
        {
          "id": 227145,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Endometriosis</span></span></span></p>"
        },
        {
          "id": 227146,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dermoid cyst</span></span></span></p>"
        },
        {
          "id": 227147,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">PID</span></span></span></p>"
        },
        {
          "id": 227148,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fibroid</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 34-year-old woman presents with dysmenorrhea. Laparoscopic finding is as shown. What is the diagnosis? (NEET PG 2024)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-121413.jpg\" style=\"height:227px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q5681049",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770860,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Endometriosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The laparoscopic image shows an ovarian cyst filled with dark brown material, characteristic of a <strong>&quot;chocolate cyst&quot; or endometriotic cyst (endometrioma</strong>). Endometriosis is a condition where endometrial tissue, which normally lines the uterus, grows outside it, commonly on the ovaries, forming cysts filled with old blood. This is why they appear dark brown, resembling melted chocolate. The key symptom of endometriosis, as seen in this patient, is dysmenorrhea (painful menstruation), which strongly supports the diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Dermoid cyst:</span></strong><span style=\"font-size:12.0pt\"> Dermoid cysts, also known as mature cystic teratomas, contain various tissue types like hair, skin, and fat. They appear heterogeneous on imaging, often with calcifications, unlike the homogeneous blood-filled appearance of an endometriotic cyst.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. PID (Pelvic Inflammatory Disease):</span></strong><span style=\"font-size:12.0pt\"> PID is an infection of the female reproductive organs, often presenting with pelvic pain, fever, and abnormal discharge. It does not typically result in cyst formation like what is seen in the image. PID usually shows inflamed and thickened structures rather than a distinct cystic mass.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Fibroid:</span></strong><span style=\"font-size:12.0pt\"> Fibroids are benign smooth muscle tumors of the uterus, usually solid and non-cystic in appearance. They do not present with blood-filled cysts on the ovaries as seen in the image.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometriosis is characterized by the presence of endometrial-like tissue outside the uterus, commonly forming chocolate cysts in the ovaries, which present as dark, blood-filled cysts on laparoscopic examination.</span></span></p>",
      "correct_choice_id": 227145,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44011,
      "choices": [
        {
          "id": 175703,
          "text": "<p><span style=\"font-size:12pt;\">Rupture membranes and confirm cord prolapse</span></p>"
        },
        {
          "id": 175704,
          "text": "<p><span style=\"font-size:12pt;\">Emergency LSCS</span></p>"
        },
        {
          "id": 175705,
          "text": "<p><span style=\"font-size:12pt;\">Put the cord above the vertex</span></p>"
        },
        {
          "id": 175706,
          "text": "<p><span style=\"font-size:12pt;\">Wait for spontaneous delivery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 24-year-old woman is in labor. The cervix is 3 cm dilated and 70% effaced. A \"bag of worms\" is felt. What is the next best step?&nbsp;</span>(INICET NOV 2023)</p>",
      "unique_key": "Q1690483",
      "question_audio": null,
      "question_video": null,
      "map_id": 32770396,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Emergency LSCS</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The description \"bag of worms\" suggests a cord prolapse, a critical situation where the umbilical cord precedes the fetus, risking compression. An emergency lower segment caesarean section (LSCS) is vital to prevent fetal distress or demise.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Rupture membranes and confirm cord prolapse:</strong> Rupturing membranes could worsen cord compression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Put the cord above the vertex:</strong> Attempting to reposition the cord is risky and generally not recommended.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Wait for spontaneous delivery:</strong> Waiting is not advisable due to the risk of cord compression and fetal hypoxia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In cases of suspected cord prolapse during labor, an emergency LSCS is the recommended course of action to safely deliver the baby and minimize the risk of complications.</span></p>",
      "correct_choice_id": 175704,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56957,
      "choices": [
        {
          "id": 227217,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Methimazole</span></span></span></p>"
        },
        {
          "id": 227218,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Carbimazole</span></span></span></p>"
        },
        {
          "id": 227219,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Iodine 131</span></span></span></p>"
        },
        {
          "id": 227220,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Propylthiouracil</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">G2 at 8 weeks diagnosed to have hyperthyroidism. What is the drug of choice? (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q2186427",
      "question_audio": null,
      "question_video": null,
      "map_id": 32771235,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Propylthiouracil</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Propylthiouracil (PTU) is the preferred medication for treating hyperthyroidism in the first trimester of pregnancy. It is considered the safest option during this period because it minimizes the risk of congenital abnormalities. Methimazole and carbimazole are associated with a rare but serious condition called aplasia cutis, where infants are born with areas of missing skin. Iodine-131 is absolutely contraindicated in pregnancy due to its radioactive nature, which can lead to fetal thyroid destruction and other complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Methimazole:</span></strong><span style=\"font-size:12.0pt\"> Although methimazole is commonly used for hyperthyroidism, it is not recommended during the first trimester of pregnancy due to its association with fetal defects like aplasia cutis, where patches of skin are absent in the newborn.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Carbimazole:</span></strong><span style=\"font-size:12.0pt\"> Similar to methimazole, carbimazole is contraindicated in the first trimester due to the risk of fetal malformations, specifically aplasia cutis. It is often avoided in early pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Iodine 131:</span></strong><span style=\"font-size:12.0pt\"> This radioactive iodine treatment is absolutely contraindicated in pregnancy as it can cause severe fetal harm, including thyroid gland destruction and developmental issues, making it highly unsafe.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the first trimester of pregnancy, propylthiouracil (PTU) is the drug of choice for hyperthyroidism due to its safer profile compared to other antithyroid medications.</span></span></p>",
      "correct_choice_id": 227220,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}